Cardiovascular diseases

I9_CVD

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I00-I99 Hospital discharge: ICD-9 — 39\|4[0-5] Hospital discharge: ICD-8 — 39\|4[0-5] Cause of death: ICD-10 — I00-I99 Cause of death: ICD-9 — 39\|4[0-5] Cause of death: ICD-8 — 39\|4[0-5] 2 out of 7 registries used, show all original rules.	273548
4. Check minimum number of events None	273548
5. Include endpoints I9_RHEUFEV I9_HYPERTENSION I9_ISCHHEART I9_PULMHEART I9_OTHHEART I9_CEREBVASC I9_DOAAC I9_DISVEINLYMPH I9_OTH	284261
6. Filter based on genotype QC (FinnGen only)	284261

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 1
First used in FinnGen datafreeze: DF10

NAME	I9_CVD
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	I9_RHEUFEV\|I9_HYPERTENSION\|I9_ISCHHEART\|I9_PULMHEART\|I9_OTHHEART\|I9_CEREBVASC\|I9_DOAAC\|I9_DISVEINLYMPH\|I9_OTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I
HD_ICD_9	39\|4[0-5]
HD_ICD_8	39\|4[0-5]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I
COD_ICD_9	39\|4[0-5]
COD_ICD_8	39\|4[0-5]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cardiovascular diseases based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	284261	143439	140822
Unadjusted period prevalence (%)	55.43	48.89	62.08
Median age at first event (years)	51.97	49.43	54.56

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8413: Matched controls
59550

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.5

323.0

2524

6460

XF400

NOMESCO Finland

ECG with 12 standard connections

5.4

323.0

1144

1690

C07AB07

ATC

bisoprolol; oral

6.3

323.0

1716

2339

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

68.3

323.0

439

TFP34

NOMESCO Finland

Electrophysiological investigation

284.8

323.0

386

I49.3

ICD-10 Finland

Ventricular premature depolarization

30.1

323.0

573

144

I47.1

ICD-10 Finland

Supraventricular tachycardia

96.6

323.0

713

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

11.7

323.0

1094

752

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

13.0

323.0

1789

1215

XF404

NOMESCO Finland

Ambulatory ECG

20.4

323.0

979

382

205

Kela drug reimbursment

Chronic hypertension

+∞

323.0

374

C08CA01

ATC

amlodipine; oral

13.6

323.0

641

359

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

12.1

323.0

1536

1077

I10

ICD-10 Finland

Essential (primary) hypertension

11.9

323.0

1098

743

B01AA03

ATC

warfarin; systemic

80.3

323.0

492

XF402

NOMESCO Finland

ECG with work load test

17.8

292.6

514

217

C03CA01

ATC

furosemide; systemic

14.3

270.4

516

271

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

7.4

250.0

676

695

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

9.4

249.0

579

462

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

19.1

238.8

409

159

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

216.2

226.2

265

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.1

222.3

804

1206

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

+∞

220.0

241

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

26.4

214.0

333

A02BC02

ATC

pantoprazole; systemic

2.2

212.7

3366

13996

I48

ICD-10 Finland

Atrial fibrillation and flutter

213.9

199.6

234

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

8.4

198.1

493

440

R00.2

ICD-10 Finland

Palpitations

4.3

197.2

851

1529

B01AB05

ATC

enoxaparin; parenteral

3.1

195.8

1273

3211

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

11.8

188.3

390

245

R07.4

ICD-10 Finland

Chest pain, unspecified

3.1

186.3

1202

3006

C09AA02

ATC

enalapril; systemic

9.0

180.0

427

350

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

34.0

178.5

261

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

13.4

174.4

340

186

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

98.0

173.6

216

C09AA05

ATC

ramipril; oral

11.3

173.1

365

238

C07AB02

ATC

metoprolol; systemic

5.8

171.0

549

708

I45.6

ICD-10 Finland

Pre-excitation syndrome

687.2

169.0

190

C09CA01

ATC

losartan; oral

9.2

166.3

391

315

N02AX02

ATC

tramadol; systemic, rectal

2.4

162.0

1713

5731

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

437.9

160.0

182

201

Kela drug reimbursment

Chronic cardiac insufficiency

38.2

158.4

226

I51.4

ICD-10 Finland

Myocarditis, unspecified

124.4

155.3

189

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

152.8

1283

3767

N02BE01

ATC

paracetamol; systemic, rectal

1.9

152.0

5942

33182

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

23.7

150.8

241

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

20.7

148.4

247

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

147.9

1831

6581

I49.1

ICD-10 Finland

Atrial premature depolarization

28.9

147.0

223

TFP40

NOMESCO Finland

Ablation treatment for a-v node re-entry activation

1208.8

146.3

163

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

60.5

145.6

192

I86.1

ICD-10 Finland

Scrotal varices

34.6

144.3

210

TPH07

NOMESCO Finland

Cathetrisation of artery

4.9

144.3

535

814

C07AA05

ATC

propranolol; systemic

2.3

143.8

1729

6121

PHD99

NOMESCO Finland

Resection of other vein

+∞

143.0

157

AA1AD

NOMESCO Finland

CT of head and brain

3.1

141.4

919

2281

K80

ICPC

Cardiac arrhythmia NOS

5.6

140.9

463

612

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

232.2

138.8

162

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

40.1

137.4

194

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

6.8

135.9

386

420

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

18.6

135.4

233

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

135.4

1176

3503

R4110

NOMESCO Finland

Physiotherapy

2.3

134.9

1461

4897

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

38.4

134.1

191

FM2CE

NOMESCO Finland

9.0

133.8

316

256

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

4.0

132.1

606

1138

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

129.8

3211

15018

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

182.7

128.5

152

R06.0

ICD-10 Finland

Dyspnoea

2.4

124.5

1324

4379

R00.0

ICD-10 Finland

Tachycardia, unspecified

4.6

123.2

484

781

207

Kela drug reimbursment

Chronic arrhythmias

337.2

122.9

141

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

67.5

122.5

159

WX892

NOMESCO Finland

Monitored bed care

4.3

122.4

512

880

B01AF01

ATC

rivaroxaban; oral

23.0

122.4

197

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

43.5

121.7

169

127

Kela drug reimbursment

Transplant complication

18.8

121.5

208

M79.6

ICD-10 Finland

Pain in limb

1.9

120.3

2229

9351

I73.0

ICD-10 Finland

Raynaud syndrome

16.5

119.4

214

UJF32

NOMESCO Finland

Coloscopy

2.7

119.0

943

2647

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

10.3

118.6

260

183

Z94.0

ICD-10 Finland

Kidney transplant status

34.5

118.2

172

I34.1

ICD-10 Finland

Mitral (valve) prolapse

58.8

117.2

155

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

114.7

1350

4672

L04AA06

ATC

mycophenolic acid; systemic

15.5

113.9

209

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

112.7

1192

3913

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

85.2

112.6

142

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

22.4

111.1

180

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

444.4

109.1

124

I88.0

ICD-10 Finland

Nonspecific mesenteric lymphadenitis

444.4

109.1

124

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

13.9

108.9

208

108

SPAT1097

SPAT

Recording of ECG

3.5

105.5

565

1205

I25.1

ICD-10 Finland

Atherosclerotic heart disease

429.8

105.4

120

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

105.4

1348

4831

TK800

NOMESCO Finland

Hemodialysis

27.9

104.2

159

XF600

NOMESCO Finland

Bloodpressure measurement

3.5

103.1

542

1139

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

73.0

102.8

132

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

27.4

101.8

156

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.5

101.4

891

2643

R51.80

ICD-10 Finland

Headache

2.0

101.2

1647

6512

I50.9

ICD-10 Finland

Heart failure, unspecified

+∞

97.3

107

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

+∞

97.3

107

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

25.5

97.3

152

N03AX16

ATC

pregabalin; oral

2.5

95.8

862

2587

I47.2

ICD-10 Finland

Ventricular tachycardia

94.9

95.5

119

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

72.4

94.2

121

WX002

NOMESCO Finland

Sedation and analgesia

2.4

93.2

882

2717

B01AF02

ATC

apixaban; oral

62.6

93.2

122

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

15.5

93.0

170

A11CC03

ATC

alfacalcidol; systemic

14.2

92.5

175

J01AA02

ATC

doxycycline; systemic

1.6

92.3

3612

18773

PHM99

NOMESCO Finland

Endovenous obliteration of other vein

+∞

91.9

101

AQ1

Conventional electrophysiological examination

737.3

91.7

103

C10AA05

ATC

atorvastatin; oral

4.9

91.6

336

502

WX402

NOMESCO Finland

General anaesthesia

2.1

91.0

1204

4352

ZX120

NOMESCO Finland

Intravenous

3.1

90.7

558

1318

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

90.7

2435

11357

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.5

89.6

813

2447

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

89.2

2317

10683

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

129.0

89.2

108

C09CA06

ATC

candesartan; oral

2.7

86.5

662

1804

TFP35

NOMESCO Finland

Electroanatomical mapping

353.4

86.4

XX3BT

NOMESCO Finland

Other labeling with X-ray guidance

42.7

85.6

119

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

85.2

2407

11351

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

346.2

84.6

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

84.4

84.1

106

N18.8

ICD-10 Finland

Other chronic renal failure

22.0

83.2

135

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

21.2

82.9

136

K04

ICPC

Palpitations/awareness of heart

3.5

82.7

444

946

N05BA04

ATC

oxazepam; oral

1.9

82.6

1543

6360

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

81.9

1762

7619

B01AC04

ATC

clopidogrel; oral

103.3

81.8

101

R50.9

ICD-10 Finland

Fever, unspecified

2.0

81.6

1241

4734

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

331.6

81.0

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.1

80.6

1129

4164

R42

ICD-10 Finland

Dizziness and giddiness

2.2

80.5

986

3431

H02AB06

ATC

prednisolone; systemic

1.7

80.3

2368

11266

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

18.6

80.0

137

M03BX02

ATC

tizanidine; oral

1.6

80.0

3245

16814

C03DA01

ATC

spironolactone; oral

5.1

79.7

282

405

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

57.9

79.4

105

A02BC05

ATC

esomeprazole; systemic

1.8

79.0

1548

6474

TFP20

NOMESCO Finland

Cardiodefibrillation

220.8

78.7

B03XA02

ATC

darbepoetin alfa; parenteral

61.5

78.6

103

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

53.8

78.5

105

C08CA02

ATC

felodipine; oral

21.0

76.6

126

C01AA05

ATC

digoxin; systemic

37.2

76.4

109

Z49.1

ICD-10 Finland

Extracorporeal dialysis

70.2

76.1

P01AB01

ATC

metronidazole; oral, rectal

1.7

75.8

2199

10378

A12AA04

ATC

calcium carbonate; oral

34.3

75.8

110

WX872

NOMESCO Finland

Intensive care

7.4

75.0

198

193

XFE00

NOMESCO Finland

Epicardial ultrasonography

14.3

74.9

141

J01MA02

ATC

ciprofloxacin; systemic

1.8

72.9

1589

6863

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

42.5

72.7

101

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.4

71.7

686

2113

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

52.9

71.7

C08CA05

ATC

nifedipine; systemic

6.1

71.1

214

252

J01DB01

ATC

cefalexin; oral

1.6

71.1

6300

38837

C08CA13

ATC

lercanidipine; oral

18.2

70.9

122

XF602

NOMESCO Finland

Bloodpressure monitoring

18.5

70.7

121

Q23.11

ICD-10 Finland

Bicuspid aortic valve

20.5

70.6

117

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

71.5

70.1

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

70.0

1300

5312

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

40.8

69.3

N02AA05

ATC

oxycodone; systemic

4.1

69.1

299

528

JHB00

NOMESCO Finland

Hemorrhoidectomy

20.4

68.8

114

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

68.7

936

3396

ZXA00

NOMESCO Finland

Right side

2.1

68.4

870

3066

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

63.7

68.3

137

Kela drug reimbursment

Uraemia requiring dialysis

50.7

68.2

R55

ICD-10 Finland

Syncope and collapse

2.6

67.6

576

1664

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

67.1

1533

6702

I84.5

ICD-10 Finland

External hemorrhoids without complication

9.5

66.9

152

115

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

6.0

66.1

201

240

M54.5

ICD-10 Finland

Low back pain

1.6

66.1

2167

10499

J01FF01

ATC

clindamycin; systemic

1.8

65.6

1427

6135

I42.0

ICD-10 Finland

Dilated cardiomyopathy

527.6

65.4

AN2

Balloon angioplasty, including several vessels

+∞

65.4

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

+∞

65.4

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.4

65.2

351

748

C10AA01

ATC

simvastatin; oral

5.4

64.9

215

286

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

13.7

64.9

124

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

13.1

64.7

126

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

520.4

64.5

C07AG02

ATC

carvedilol; oral

55.3

63.9

G44.2

ICD-10 Finland

Tension-type headache

1.9

63.7

1043

4059

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.6

63.2

204

263

H02AB09

ATC

hydrocortisone; systemic

4.2

61.7

263

458

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.5

61.7

528

1528

TFP41

NOMESCO Finland

Ablation treatment of manifest ancillary pathway

+∞

60.9

WZC30

NOMESCO Finland

Teaching

2.5

60.6

544

1615

N05AH04

ATC

quetiapine; oral

1.7

60.6

1562

7052

Congenital heart failure surgery

17.7

60.0

104

A02BC01

ATC

omeprazole; systemic

1.8

59.8

1231

5185

N06AX11

ATC

mirtazapine; oral

1.6

59.7

1744

8154

N03AX12

ATC

gabapentin; oral

2.4

59.5

554

1678

R03AC02

ATC

salbutamol; inhalant

1.5

59.4

3855

21728

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

8.9

59.2

139

112

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

37.5

59.1

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

477.1

59.1

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

+∞

59.1

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

59.0

446

1200

V03AE01

ATC

polystyrene sulfonate; oral

102.8

58.4

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

60.3

58.0

WX882

NOMESCO Finland

High dependency care

3.6

57.9

296

605

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.6

57.9

222

348

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

101.3

57.5

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.9

57.0

257

472

XF405

NOMESCO Finland

Symptom ECG

19.1

56.8

R07.3

ICD-10 Finland

Other chest pain

2.7

56.8

437

1189

R53

ICD-10 Finland

Malaise and fatigue

1.7

56.6

1446

6497

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.3

55.8

590

1903

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

55.8

1048

4270

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.5

55.7

291

606

I45.8

ICD-10 Finland

Other specified conduction disorders

441.2

54.6

I84.4

ICD-10 Finland

External hemorrhoids with other complications

19.7

54.5

Catheterization and pressure measurement of the left side of the heart

33.2

54.3

WX110

NOMESCO Finland

Local anesthesy

1.5

54.1

5986

37234

103

Kela drug reimbursment

Diabetes, insulin-treated

2.2

54.0

589

1929

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

434.0

53.7

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

152.1

53.6

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

+∞

53.6

L04AX01

ATC

azathioprine; systemic

2.8

53.4

378

976

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

53.1

1908

9370

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.2

52.9

582

1912

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

52.9

438

1243

I50.1

ICD-10 Finland

Left ventricular failure

+∞

52.7

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

52.5

3927

22551

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

52.3

832

3191

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

52.2

4958

29792

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

91.3

51.4

A02BC03

ATC

lansoprazole; oral

2.0

51.4

738

2721

L04AD01

ATC

ciclosporin; systemic

5.3

51.3

172

233

ZXA05

NOMESCO Finland

Left side

2.0

51.2

767

2873

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

23.8

50.7

B05DA

ATC

Isotonic solutions

41.6

50.4

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

+∞

50.0

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

+∞

50.0

SPAT1262

SPAT

Handing over of treatment supplies

2.1

50.0

657

2335

UJH02

NOMESCO Finland

Anoscopy

5.9

49.8

153

186

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

6.7

49.7

140

151

M25.5

ICD-10 Finland

Pain in joint

1.6

49.5

1605

7661

Z49.2

ICD-10 Finland

Other dialysis

47.8

49.4

Q23.0

ICD-10 Finland

Congenital stenosis of aortic valve

52.3

49.4

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.0

48.8

319

782

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

48.7

1233

5502

N18.0

ICD-10 Finland

End-stage renal disease

51.5

48.5

PH5GT

NOMESCO Finland

Endovascular embolisation of spermatic vein with radiological guidance

+∞

48.1

I44.2

ICD-10 Finland

Atrioventricular block, complete

+∞

48.1

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.5

48.1

432

1282

S18

ICPC

Laceration/cut

1.5

48.0

2105

10784

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

10.0

47.8

105

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.8

47.7

149

185

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

63.2

47.7

K85

ICPC

Elevated blood pressure

3.4

47.6

256

546

N05CF01

ATC

zopiclone; oral

1.8

47.3

933

3851

TFP42

NOMESCO Finland

Ablation treatment of hidden ancillary pathway

+∞

47.2

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

3.6

47.2

234

467

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.3

47.1

157

211

I83

ICD-10 Finland

Varicose veins of lower extremities

9.5

46.6

105

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.9

46.5

212

394

G47.3

ICD-10 Finland

Sleep apnoea

2.3

46.4

502

1633

C01BC04

ATC

flecainide; systemic

101.5

46.3

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.8

46.1

853

3444

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

24.5

46.0

J01FA06

ATC

roxithromycin; oral

1.5

45.8

1803

9000

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

369.3

45.6

I95.1

ICD-10 Finland

Orthostatic hypotension

14.6

45.4

N06AB04

ATC

citalopram; systemic

1.8

45.3

954

4020

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

81.2

45.3

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

45.2

980

4168

CKC12

NOMESCO Finland

Photocoagulation of retina

4.3

45.1

184

308

I84.3

ICD-10 Finland

External thrombosed hemorrhoids

11.3

45.0

G43.9

ICD-10 Finland

Migraine, unspecified

1.9

45.0

720

2761

N17.9

ICD-10 Finland

Acute renal failure, unspecified

10.8

44.6

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.8

44.6

947

4000

M01AH05

ATC

etoricoxib; oral

1.5

44.6

2480

13314

H02AB04

ATC

methylprednisolone; systemic

2.2

44.1

484

1587

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

125.8

43.9

I88.9

ICD-10 Finland

Nonspecific lymphadenitis, unspecified

7.6

43.8

112

105

C02AC05

ATC

moxonidine; oral

96.1

43.7

R60.0

ICD-10 Finland

Localized oedema

2.7

43.5

324

864

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

42.7

43.5

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

43.4

1402

6659

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

43.4

2652

14483

Q21.10

ICD-10 Finland

Persistent ostium secundum

5.7

43.4

136

170

Q25.1

ICD-10 Finland

Coarctation of aorta

15.5

43.1

A10AE04

ATC

insulin glargine; parenteral

2.4

42.9

395

1185

I82.80

ICD-10 Finland

Emboli and thrombosis in the subclavian vein

+∞

42.7

B05DB

ATC

Hypertonic solutions

45.9

42.6

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

7.3

42.5

112

110

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

6.9

42.3

116

121

M79.1

ICD-10 Finland

Myalgia

1.8

42.2

908

3847

R11

ICD-10 Finland

Nausea and vomiting

1.9

42.1

733

2896

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

42.0

823

3383

I44.1

ICD-10 Finland

Atrioventricular block, second degree

340.6

42.0

J01MA12

ATC

levofloxacin; systemic

2.1

41.9

528

1839

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

41.8

3801

22254

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

174.4

41.5

K84

ICPC

Heart disease other

31.0

41.5

H3603, E103

ICD-10 Finland

6.5

41.4

118

130

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

41.4

1276

5981

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

7.2

41.3

110

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

118.6

41.2

Z71.8

ICD-10 Finland

Other specified counselling

1.5

41.1

2163

11442

PHM79

NOMESCO Finland

Endovenous obliteration of v.saphena anterior

+∞

40.9

B03XA01

ATC

erythropoietin; parenteral

34.4

40.3

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

116.2

40.3

SPAT1263

SPAT

Sampling

1.4

40.3

3645

21269

WX704

NOMESCO Finland

Intubation

2.3

40.2

404

1268

SGA01

NOMESCO Finland

Tooth opening as first aid

1.6

40.2

1262

5942

JN4BD

NOMESCO Finland

Extensive body CT

3.2

40.1

229

511

AR1

Catheter ablation of arrhythmia, target: AV node reentry activation (AVNRT)

+∞

40.0

I35.0

ICD-10 Finland

Aortic (valve) stenosis

+∞

40.0

I49

ICD-10 Finland

Other cardiac arrhythmias

6.3

39.8

116

132

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.2

39.7

444

1468

K95

ICPC

Varicose veins of leg

12.0

39.4

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

319.1

39.3

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

319.1

39.3

L04AA01

ATC

[U] ciclosporin; systemic

9.5

39.2

Q23.10

ICD-10 Finland

Congenital insufficiency of aortic valve

42.7

39.2

N06AX16

ATC

venlafaxine; oral

1.7

39.1

975

4312

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

+∞

39.1

M01AB05

ATC

diclofenac; systemic, rectal

1.4

38.9

2979

16859

I49.5

ICD-10 Finland

Sick sinus syndrome

163.6

38.8

N06AX21

ATC

duloxetine; oral

2.0

38.8

518

1847

G04BE03

ATC

sildenafil; oral

33.2

38.7

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

38.5

414

1342

D68.8

ICD-10 Finland

Other specified coagulation defects

6.5

38.2

108

118

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.0

38.2

526

1900

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

+∞

38.1

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

+∞

38.1

C08DA01

ATC

verapamil; systemic

6.2

38.1

112

129

C10AA07

ATC

rosuvastatin; oral

3.5

38.0

197

409

I44.0

ICD-10 Finland

Atrioventricular block, first degree

160.1

37.9

A46

ICD-10 Finland

Erysipelas

2.5

37.7

315

898

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

83.6

37.5

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

37.5

4188

25178

TK810

NOMESCO Finland

Hemofiltration

68.3

37.4

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

37.4

2020

10702

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

+∞

37.2

XCK10

NOMESCO Finland

Photography of fundus of eye

2.4

37.2

343

1031

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

37.0

6164

39504

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

36.8

1010

4582

TK820

NOMESCO Finland

Peritoneal dialysis

37.0

36.8

XF622

NOMESCO Finland

Measurement of minute volume of heart

40.3

36.7

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

36.6

1358

6640

I15.8

ICD-10 Finland

Other secondary hypertension

49.9

36.5

C05AA08

ATC

fluocortolone; rectal, topical

2.5

36.5

313

906

A11

ICPC

Chest pain NOS

2.6

36.4

294

823

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

+∞

36.3

AR2

Catheter ablation of arrhythmia, target: extra pathway (WPW, AVRT, PJRT)

+∞

36.3

XA800

NOMESCO Finland

Neuropsychological investigation

2.6

36.2

295

828

R52.9

ICD-10 Finland

Pain, unspecified

2.0

36.2

494

1777

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.6

36.1

288

800

602

Kela drug reimbursment

Children's severe malnutrition

4.8

36.0

131

196

J02AC01

ATC

fluconazole; systemic

1.4

35.9

2198

11908

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

8.4

35.9

R03.0

ICD-10 Finland

Elevated blood-pressure reading, without diagnosis of hypertension

3.2

35.6

204

456

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.4

35.6

332

1005

ZXA10

NOMESCO Finland

Bilateral

1.7

35.5

829

3590

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.6

35.5

281

776

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

35.4

741

3104

KA1AE

NOMESCO Finland

Kidney ultrasound examination

4.8

35.4

129

193

PHM77

NOMESCO Finland

Endovenous obliteration of v.saphena parva

+∞

35.4

UGC12

NOMESCO Finland

Flexible bronchoscopy

4.0

35.4

155

279

I45.9

ICD-10 Finland

Conduction disorder, unspecified

149.3

35.3

Z94.1

ICD-10 Finland

Heart transplant status

149.3

35.3

KMAK

NOMESCO Finland

1.3

35.2

4157

25106

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

35.1

355

1118

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

35.0

615

2432

R01AD09

ATC

mometasone; nasal

1.4

35.0

3097

17864

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.7

35.0

268

726

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.1

35.0

454

1600

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.4

34.8

311

921

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

283.2

34.8

A10BA02

ATC

metformin; oral

2.0

34.7

467

1670

C07AB03

ATC

atenolol; systemic

8.8

34.6

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

34.5

589

2305

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.5

34.2

1356

6719

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

99.6

34.2

N05BA01

ATC

diazepam; systemic, rectal

1.9

34.2

545

2082

GAE40

NOMESCO Finland

Operation on rib and soft tissues for thoracic outlet syndrome

19.9

34.0

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.1

33.9

444

1569

ZX199

NOMESCO Finland

Other rote

16.8

33.8

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.1

33.6

408

1398

PHD76

NOMESCO Finland

Resection of long saphenous vein

+∞

33.6

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

+∞

33.6

H03AA01

ATC

levothyroxine sodium; systemic

1.6

33.6

929

4216

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

3.1

33.6

197

450

196

Kela drug reimbursment

Paricalcitol and cinacalcet

142.2

33.5

K05

ICPC

Irregular heartbeat other

4.5

33.4

130

209

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

25.9

33.3

JN3AD

NOMESCO Finland

Abdominal CT examination

2.7

33.3

249

667

B01AB10

ATC

tinzaparin; parenteral

3.2

33.1

191

430

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

8.3

33.1

Z49.0

ICD-10 Finland

Preparatory care for dialysis

52.2

33.1

TAB00

NOMESCO Finland

Lumbar puncture

2.4

33.0

308

932

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.8

32.9

152

287

Q21.08

ICD-10 Finland

Other specifed ventricular septal defect

4.8

32.8

119

178

I37.1

ICD-10 Finland

Pulmonary valve insufficiency

+∞

32.7

5AB14

NOMESCO Finland

33.4

32.6

SPAT1153

SPAT

Removal of sutures

1.5

32.6

1303

6461

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

32.5

3693

22061

Q21.09

ICD-10 Finland

Ventricular septal defect NOS

8.7

32.5

K06.18

ICD-10 Finland

Another gingival hyperplasia

15.0

32.5

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

32.5

330

1043

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.9

32.3

216

539

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.7

32.2

686

2887

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

22.7

32.2

TPH10

NOMESCO Finland

Sclerotherapy of varicose veins

261.7

32.1

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

31.9

961

4453

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.1

31.9

419

1484

Z31.5

ICD-10 Finland

Genetic counselling

2.0

31.9

469

1737

K30

ICD-10 Finland

Functional dyspepsia

1.9

31.8

528

2046

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

31.8

1400

7088

K04.0

ICD-10 Finland

Pulpitis

1.6

31.7

898

4098

C09CA03

ATC

valsartan; oral

9.8

31.5

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

43.7

31.4

Z99.2

ICD-10 Finland

Dependence on renal dialysis

43.7

31.4

Catheterization and pressure measurement of the right side of the heart

22.2

31.4

XF640

NOMESCO Finland

8.2

31.4

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.5

31.3

277

815

R20.2

ICD-10 Finland

Paraesthesia of skin

2.0

31.3

416

1480

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.0

31.3

463

1720

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.8

31.2

145

276

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

3.5

31.1

156

316

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.3

31.1

302

931

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

6.0

31.0

111

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

30.9

658

2768

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.3

30.9

316

1000

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

+∞

30.9

K99

ICPC

Cardiovascular disease other

15.7

30.8

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

30.7

1349

6819

V03AE02

ATC

sevelamer; oral

90.0

30.6

K94

ICPC

Phlebitis/thrombophlebitis

16.0

30.5

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

30.4

686

2934

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

30.4

397

1403

R4190

NOMESCO Finland

Nutritional therapy

2.3

30.3

319

1024

N06AB06

ATC

sertraline; oral

1.6

30.3

896

4131

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.4

30.2

284

864

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.7

30.1

220

581

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

31.3

30.1

GD1LA

NOMESCO Finland

23.9

30.1

S06.0

ICD-10 Finland

Concussion

1.6

30.0

889

4102

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.5

30.0

150

304

PHT99

NOMESCO Finland

Injection of therapeutic or sclerosing agent into other vein

127.9

30.0

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

29.8

679

2913

N06AB10

ATC

escitalopram; oral

1.4

29.7

1762

9436

I26

ICD-10 Finland

Pulmonary embolism

26.7

29.7

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.6

29.7

145

288

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

7.3

29.6

SPAT1255

SPAT

Intravenous administration of medicine

2.5

29.6

260

762

E66.8

ICD-10 Finland

Other obesity

2.4

29.4

280

856

UJF30

NOMESCO Finland

Ileoscopy through colon

2.0

29.3

431

1595

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

29.3

275

836

J01MA14

ATC

moxifloxacin; systemic

2.5

29.3

250

723

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

7.0

29.3

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

29.3

445

1670

N05CF02

ATC

zolpidem; oral

1.7

29.3

673

2894

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

29.2

540

2170

FXA10

NOMESCO Finland

Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure

33.2

29.2

UKC02

NOMESCO Finland

Cystoscopy

2.2

29.1

316

1029

Q21.30

ICD-10 Finland

Tetralogy of Fallot

24.6

29.1

K93

ICPC

Pulmonary embolism

124.3

29.1

Electrophysiological Special Examination

+∞

29.1

I84.6

ICD-10 Finland

Residual hemorrhoidal skin tags

18.3

29.0

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.5

28.9

242

692

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

8.2

28.9

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

28.8

533

2142

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

65.8

28.8

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

28.7

950

4503

H53.1

ICD-10 Finland

Subjective visual disturbances

2.2

28.5

322

1069

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

233.0

28.5

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

28.4

1124

5548

SPAT1301

SPAT

No procedures

1.3

28.4

2330

13164

I80

ICD-10 Finland

Phlebitis and thrombophlebitis

10.4

28.3

N05AH03

ATC

olanzapine; systemic

1.8

28.2

535

2168

I27.0

ICD-10 Finland

Primary pulmonary hypertension

+∞

28.1

C01BD01

ATC

amiodarone; systemic

+∞

28.1

Q21.11

ICD-10 Finland

Paten or persistent foramen ovale

6.9

28.1

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

28.1

1024

4963

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

6.5

28.0

H43.1

ICD-10 Finland

Vitreous haemorrhage

6.2

27.9

SPAT1260

SPAT

Consultation of another employee

1.5

27.7

1225

6189

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

27.6

1374

7105

I50.0

ICD-10 Finland

Congestive heart failure

225.9

27.6

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.1

27.6

353

1238

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

3.0

27.5

172

412

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

27.4

372

1333

N03AX09

ATC

lamotrigine; oral

1.9

27.4

465

1814

T90

ICPC

Diabetes non-insulin dependent

2.4

27.4

241

709

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

80.5

27.1

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

43.8

27.1

L17

ICPC

Foot/toe symptom/complaint

1.4

27.1

1497

7891

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

27.1

358

1271

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

27.1

6807

45010

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

26.5

27.1

C09DA01

ATC

losartan and diuretics; oral

13.4

27.0

GD1AD

NOMESCO Finland

Thorax CT examination

4.3

27.0

109

183

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

26.9

4256

26351

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

5.4

26.8

115

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

26.7

2376

13564

I37.0

ICD-10 Finland

Pulmonary valve stenosis

221.6

26.7

A10AA02

ATC

3.0

26.6

166

397

WW200

NOMESCO Finland

Immunization

2.8

26.6

183

467

SPAT1283

SPAT

Restricted health certificate

1.3

26.4

2814

16491

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

8.1

26.4

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.5

26.4

228

664

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

26.4

3421

20606

A41.9

ICD-10 Finland

Sepsis, unspecified

3.3

26.3

142

306

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

26.3

790

3650

C07AA07

ATC

sotalol; systemic

78.2

26.3

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.8

26.2

184

474

A10AA01

ATC

3.0

26.1

165

398

N03AE01

ATC

clonazepam; systemic

2.6

26.0

211

593

N03AG01

ATC

valproic acid; systemic, rectal

2.0

25.9

383

1421

G54.0

ICD-10 Finland

Brachial plexus disorders

3.0

25.9

161

383

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

25.9

438

1708

N19

ICD-10 Finland

Unspecified kidney failure

12.1

25.9

A28

ICPC

Limited function/disability NOS

2.4

25.7

245

750

R4120

NOMESCO Finland

Occupational therapy

2.1

25.6

303

1027

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.9

25.6

426

1651

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

110.1

25.5

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

25.5

950

4621

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

25.4

I45.0

ICD-10 Finland

Right fascicular block

+∞

25.4

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

+∞

25.4

TFJ02

NOMESCO Finland

Muscle biopsy of heart

+∞

25.4

R52.0

ICD-10 Finland

Acute pain

2.4

25.4

239

728

3025

Kela drug reimbursment

Calcium carbonate

75.8

25.4

M54.6

ICD-10 Finland

Pain in thoracic spine

1.9

25.3

411

1580

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.0

25.2

365

1344

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.9

25.2

398

1514

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.5

25.1

211

605

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.7

25.1

522

2178

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

24.9

570

2444

X58

ICD-10 Finland

Exposure to other specified factors

1.5

24.9

1040

5182

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

206.9

24.9

FXA20

NOMESCO Finland

Total cardiopulmonary bypass in deep hypothermia and circulatory arrest at concurrent surgical procedure

206.9

24.9

Q22.1

ICD-10 Finland

Congenital pulmonary valve stenosis

9.6

24.9

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

6.6

24.7

R02

ICPC

Shortness of breath/dyspnoea

1.6

24.6

673

3035

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.4

24.5

1617

8780

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

73.4

24.5

I80.20

ICD-10 Finland

Phlebitis and thrombophlebitis in the iliac vein

+∞

24.5

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

+∞

24.5

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

21.3

24.3

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1442

2365

3.40

321.27

2.2

1.8

ug/l

1.9

2.0

0.00

1305

2098

(3020891) Body temperature

1593

2796

3.18

320.55

5.6

3.7

—

(3024928) Oxygen saturation in Venous blood

1107

1494

4.12

319.55

5.6

3.8

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1610

2854

3.15

318.98

5.9

3.7

1.8

0.39

1511

2654

(3028026) IgM [Mass/volume] in Serum or Plasma

3202

8142

2.23

318.35

1.8

g/l

1.3

0.96

2990

7546

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1163

1647

3.93

316.22

5.2

2.5

u/ml

946.3

6451.5

0.49

(3018405) Lactate [Moles/volume] in Arterial blood

1396

2268

3.43

315.25

4.4

3.3

mmol/l

1.3

1.4

1.11

1377

2228

(3002385) Erythrocyte distribution width [Ratio]

33478

161042

1.60

314.68

18.8

9.8

13.5

13.4

31.85

33016

157196

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6234

20258

1.79

313.80

3.2

2.2

e6/l

3.4

3.5

0.29

3322

10251

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3311

8622

2.18

310.81

4.6

2.6

mmol/l

1.2

5.12

2969

7325

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1701

3173

3.00

310.37

4.9

2.8

52.3

48.5

5.91

1677

3135

(3027456) Digoxin [Moles/volume] in Serum or Plasma

360

21.49

309.18

2.9

2.7

nmol/l

0.8

0.9

0.70

273

(3020564) Creatinine [Moles/volume] in Serum or Plasma

40329

195083

3.07

307.65

17.0

8.0

umol/l

74.4

70.2

102.29

40319

194952

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

19346

59251

2.42

307.65

8.9

4.4

mmol/l

1.2

59.80

16503

50042

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2577

4453

3.29

307.65

12.1

8.0

1.4

1.23

2566

4423

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4558

10178

2.61

307.65

1.9

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1817

3327

3.06

307.65

8.0

4.6

mg/l

1.4

1.1

73.16

1739

3153

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

12332

31012

2.64

307.65

2.4

1.8

u/l

221.6

207.1

0.46

11778

29144

(3037522) Nuclear Ab [Titer] in Serum

7388

22088

1.99

307.65

1.5

1.3

titre

522.8

534.8

0.18

1420

3992

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

36510

177179

1.82

307.65

4.4

3.2

mmol/l

4.6

4.9

307.65

34864

167421

(3023103) Potassium [Moles/volume] in Serum or Plasma

39327

176186

3.57

307.65

16.9

7.1

mmol/l

3.9

10.10

38638

169605

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15129

52826

1.86

307.65

3.8

2.8

u/l

33.3

30.0

2.37

14450

50335

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3340

4093

4.74

307.65

2.3

1.4

ug/l

9.1

3.2

23.27

2994

3507

(3007853) Bacteria identified in Skin by Aerobe culture

5425

16075

1.96

307.65

1.9

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

15251

37375

2.90

307.65

3.3

1.7

ng/l

56.2

16.1

2.49

8461

15115

(3018010) Neutrophils/100 leukocytes in Blood

20436

79075

1.78

307.65

7.1

5.3

56.6

55.3

48.55

19440

74533

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3381

3351

5.88

307.65

3.4

1.5

ng/l

134.5

54.8

16.99

2982

2852

(40758558) Short blood count panel - Blood

10685

38879

1.66

307.65

7.8

6.4

—

(3022096) Basophils/100 leukocytes in Blood

19547

72989

1.84

307.65

7.4

5.6

0.7

2.12

18509

68262

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6610

21243

1.82

307.65

3.0

2.2

e6/l

1.0

0.20

3688

11194

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

19221

74369

1.74

307.65

4.2

3.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

3806

7508

2.93

307.65

9.9

5.9

mmol/l

1.3

0.52

3674

7205

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2525

4132

3.47

307.65

7.7

5.3

mmol/l

24.4

24.3

0.05

2379

3772

(3019069) Monocytes/100 leukocytes in Blood

20190

76228

1.84

307.65

7.6

5.7

8.3

8.2

8.94

19222

71797

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2147

3658

3.31

307.65

4.2

2.4

g/l

3.5

1.01

2044

3459

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2497

4925

2.87

307.65

7.6

3.9

mmol/l

24.1

0.32

2267

4513

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5241

15356

1.98

307.65

3.5

2.5

umol/l

7.0

6.9

0.07

4488

13047

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3957

10526

2.15

307.65

2.7

2.4

g/l

0.2

4.72

3727

9932

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

9857

34105

1.75

307.65

2.5

1.9

—

(3031040) Bacteria [#/volume] in Urine by Automated count

25228

106196

1.71

307.65

4.5

3.3

e6/l

1447.7

1239.0

0.21

375

1179

(3030467) Casts [#/volume] in Urine by Automated count

10800

35958

1.85

307.65

3.7

2.3

e6/l

0.3

2.19

8217

25646

(3001604) Monocytes [#/volume] in Blood

21375

79944

1.91

307.65

7.2

5.5

e9/l

0.6

0.5

35.95

18956

70214

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3871

6582

3.42

307.65

10.2

6.7

g/l

123.6

125.2

3.81

3752

6293

(3020779) Urea [Moles/volume] in Serum or Plasma

4360

6150

4.19

307.65

12.0

4.6

mmol/l

8.2

6.1

75.43

4227

5887

(3005719) IgG [Mass/volume] in Serum or Plasma

4082

10806

2.17

307.65

2.9

2.5

g/l

10.4

10.5

1.31

3798

9898

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6007

12130

2.97

307.65

9.7

3.9

mmol/l

1.1

1.0

10.62

5723

11359

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2047

3934

2.93

307.65

2.1

1.7

g/l

0.2

3.54

1967

3736

(36304419) Bacteria [Presence] in Urine

10723

36279

1.81

307.65

3.5

2.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

29113

121671

1.94

307.65

4.5

3.2

mm/h

10.4

8.5

105.88

27550

113287

(3020630) Protein [Mass/volume] in Serum or Plasma

2896

6058

2.72

307.65

2.5

2.3

g/l

66.7

67.8

9.85

2711

5603

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

29941

117399

2.29

307.65

8.5

5.7

u/l

75.8

74.6

5.19

28583

110148

(3004588) Protein electrophoresis panel - Serum or Plasma

2204

4612

2.69

307.65

2.2

2.0

—

(3026782) Osmolality of Urine

7793

24215

1.92

307.65

3.2

2.1

mosm/kgh2o

538.1

564.8

12.16

6814

20334

(3014007) Fractional oxyhemoglobin in Arterial blood

2581

4461

3.29

307.65

12.3

8.1

94.0

94.8

6.92

2571

4446

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3112

6326

2.81

307.65

11.5

6.6

mmol/l

24.6

0.01

3094

6275

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

10267

37925

1.62

307.65

1.7

1.5

mmol/l

1.5

1.3

26.18

8934

32870

(3004119) Hemoglobin [Mass/volume] in Venous blood

2547

4404

3.29

307.65

5.0

2.8

g/l

130.1

135.5

20.76

2493

4300

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2016

3352

3.39

307.65

4.7

3.0

1.4

0.56

2008

3328

(3026250) Tacrolimus [Mass/volume] in Blood

584

195

16.52

307.65

40.0

32.6

ug/l

7.6

7.0

3.07

549

171

(3016502) Oxygen saturation in Arterial blood

4125

6893

3.50

307.65

10.0

6.6

96.1

96.6

4.35

3984

6601

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2365

3947

3.40

307.65

12.7

7.6

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1592

1299

6.89

307.65

1.1

115.7

118.2

1.66

1481

1154

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

7550

25649

1.73

307.65

1.6

1.5

pmol/l

39359692.8

35081148.8

0.22

6555

22052

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5138

12880

2.33

307.65

2.3

2.1

nmol/l

362.5

382.1

9.25

4779

11947

(3015736) pH of Urine

15555

61938

1.58

307.65

3.5

2.6

5.6

5.8

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2582

4442

3.30

307.65

12.2

8.0

0.7

0.03

2569

4417

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

35880

165776

2.09

307.65

13.2

6.6

ml/min/173m2

91.1

92.8

40.61

30262

130605

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4090

8081

2.94

307.65

6.6

3.4

kpa

5.9

5.8

1.89

3974

7817

(3024561) Albumin [Mass/volume] in Serum or Plasma

17096

52767

2.27

307.65

6.0

3.9

g/l

36.5

37.2

56.07

16101

48879

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2389

3170

4.29

307.65

3.4

2.5

172.3

160.7

6.88

2278

2997

(3009261) Glucose [Presence] in Urine by Test strip

19875

82079

1.59

307.65

3.9

2.7

estimate

0.0

0.36

3976

15079

(4306422)

1630

1397

6.57

307.65

1.2

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2104

4080

2.90

307.65

2.0

1.7

g/l

1.2

1.23

2024

3887

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2907

6315

2.62

307.65

6.1

3.4

kpa

5.1

0.76

2757

5899

(3032080) INR in Blood by Coagulation assay

16149

36873

3.22

307.65

8.0

2.5

inr

1.2

1.0

37.85

5200

12275

(3006315) Basophils [#/volume] in Blood

21453

80211

1.91

307.65

7.2

5.5

e9/l

0.0

6.35

19008

70333

(3021601) Nitrite [Presence] in Urine by Test strip

19711

81394

1.59

307.65

5.2

3.7

estimate

0.0

2.13

4169

15404

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3047

7277

2.38

307.65

1.7

1.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

17664

52846

2.39

307.65

8.3

4.1

mmol/l

1.2

64.08

16407

47660

(3026008) Bacteria identified in Urine by Culture

10530

37522

1.70

307.65

2.8

2.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4497

10022

2.61

307.65

1.8

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

39228

175365

3.53

307.65

16.7

7.1

mmol/l

139.6

139.7

31.97

38597

169308

(3044889) 12 lead EKG panel

27880

100516

2.46

307.65

3.6

2.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

3374

6781

2.86

307.65

5.9

3.3

kpa

4.9

4.8

1.43

3265

6549

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7303

12758

3.55

307.65

3.3

1.8

30.0

28.9

37.46

7095

12347

(3020682) Albumin/Creatinine [Ratio] in Urine

10882

27623

2.53

307.65

4.6

3.5

mg/mmol

13.1

6.6

11.70

7347

17082

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4054

10965

2.12

307.65

3.3

2.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6505

14786

2.65

307.65

3.1

1.6

g/l

2.4

2.5

25.11

6125

13605

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

35337

166164

1.89

307.65

4.3

3.1

mmol/l

5.9

5.6

241.71

33284

154640

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

8588

15868

3.44

307.65

3.8

1.8

ng/l

612.3

169.7

12.68

5559

7576

(3021589) Normoblasts [#/volume] in Blood

18696

73814

1.67

307.65

10.7

7.1

e9/l

0.0

1.10

15529

60453

(3021960) Folate [Moles/volume] in Serum or Plasma

7917

25397

1.86

307.65

1.6

1.4

nmol/l

19.9

20.7

4.52

7099

22149

(3044640) Blood type and Crossmatch panel - Blood

12828

45867

1.75

307.65

2.6

1.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10464

13517

5.25

307.65

3.4

1.5

ng/l

945.3

312.9

35.98

8658

9947

(3001122) Ferritin [Mass/volume] in Serum or Plasma

19839

81602

1.60

307.65

3.4

2.5

ug/l

106.0

83.3

28.49

18882

77175

(3012544) pH of Venous blood

4228

8205

3.00

307.65

6.5

3.3

7.4

1.45

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

35285

168638

1.78

307.65

3.9

2.9

mmol/l

1.3

1.2

109.11

33474

158792

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

39933

198135

2.40

307.65

11.7

7.0

u/l

28.5

26.5

42.88

39054

191590

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1546

1553

5.59

307.65

1.3

1.2

u/ml

4.4

3.6

1.39

694

715

(3027801) Oxygen [Partial pressure] in Arterial blood

4602

7991

3.39

307.65

9.4

6.1

kpa

13.0

14.3

28.60

4424

7619

(3011985) Renin [Units/volume] in Plasma

947

1014

5.18

307.65

1.7

2.0

mu/l

60.1

60.6

0.02

869

936

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6066

13125

2.77

307.65

3.2

1.7

23.3

25.5

21.13

5318

11400

(3002582) Erythrocytes [#/volume] in Urine

11843

39771

1.86

307.65

3.8

2.4

e6/l

91.9

73.0

0.51

9245

29026

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

38864

182931

2.66

307.65

15.7

7.7

mg/l

20.4

21.0

3.41

31826

132894

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

10290

31337

2.04

307.65

2.4

2.0

mg/l

2.8

2.6

15.33

9033

26710

(3006504) Eosinophils/100 leukocytes in Blood

20102

75734

1.84

307.65

7.3

5.5

2.8

2.9

3.22

19038

70807

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4602

7994

3.39

307.65

9.4

6.2

kpa

5.1

0.16

4427

7617

(3000850) Epithelial cells [#/volume] in Urine

8396

26248

1.92

307.65

3.1

2.0

e6/l

6.4

6.9

1.61

7504

22481

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

884

912

5.37

307.65

1.5

1.3

pmol/l

380.4

331.4

0.66

717

697

(3042936) Bacteria identified in Isolate by Culture

6187

16692

2.19

307.65

2.3

1.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

24004

78147

2.53

307.65

5.9

3.2

mmol/l

6.6

6.3

50.99

22604

69571

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2790

6066

2.61

307.65

6.1

3.4

mmol/l

1.5

1.2

4.23

2074

4282

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

11840

28350

2.76

307.65

2.3

1.5

mg/l

1.1

0.9

5.96

8767

20341

(3019198) Lymphocytes [#/volume] in Blood

21964

83815

1.87

307.65

7.2

5.4

e9/l

2.0

7.33

19834

75039

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1581

2601

3.40

307.65

2.9

2.0

ug/l

619.6

354.4

0.89

1455

2295

(4268621)

1097

1093

5.58

307.65

2.4

2.2

—

(40761511) CBC panel - Blood by Automated count

39784

197956

2.29

307.65

14.3

7.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

7036

16659

2.56

307.65

3.1

1.7

umol/l

13.7

16.6

1.75

6648

15454

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1591

1493

5.99

307.65

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

4494

7726

3.42

307.65

17.8

2.4

inr

1.2

1.0

20.12

682

1541

(3002032) Base excess in Venous blood by calculation

4069

8031

2.94

307.65

6.7

3.4

mmol/l

1.7

1.6

0.12

3344

6378

(3013512) EKG study

10777

30824

2.21

307.65

3.4

2.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1596

796

11.30

307.65

6.3

2.4

u/ml

0.3

6.99

915

304

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6399

15924

2.40

307.65

1.9

1.6

—

(3018095) Leukocytes [#/volume] in Urine

13852

50360

1.74

307.65

4.4

2.8

e6/l

64.6

67.8

0.21

9975

32166

(3019309) Folate [Moles/volume] in Red Blood Cells

5928

17514

1.98

307.65

1.8

1.6

nmol/l

1192.9

1141.7

3.78

4785

13273

(3002030) Lymphocytes/100 leukocytes in Blood

20732

80211

1.79

307.65

7.3

5.5

29.0

30.6

91.31

19683

75218

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

36851

178748

1.87

307.65

4.7

3.3

mmol/l

2.8

3.0

307.65

34959

167600

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

1157

917

7.04

307.65

1.1

94.3

95.1

0.34

1105

851

(3037467) Urinalysis macro (dipstick) panel - Urine

26799

113993

1.75

307.65

4.7

3.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1827

3146

3.26

307.65

2.1

1.8

g/l

1.5

1.3

7.96

1593

2705

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7582

15192

3.09

307.65

5.0

3.3

mmol/l

0.8

16.30

7208

14164

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1967

3294

3.36

307.65

4.6

3.0

0.7

0.18

1893

3116

(3007930) Methemoglobin/Hemoglobin.total in Blood

1604

2786

3.22

307.65

6.0

3.8

0.9

0.45

1507

2590

(3015377) Calcium [Moles/volume] in Serum or Plasma

12393

44213

1.74

307.65

3.4

3.0

mmol/l

2.3

2.4

4.49

11225

39556

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

35712

164625

2.08

307.65

5.2

4.1

mu/l

1.8

2.1

3.33

33858

153813

(3026493) Urate [Moles/volume] in Serum or Plasma

10371

32946

1.94

307.65

2.8

1.9

umol/l

2407.8

3329.9

2.18

9358

29521

(3042733) HLA Ab [Presence] in Serum

439

117

20.64

307.65

4.9

3.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

13960

50462

1.75

307.65

1.9

1.6

pmol/l

97.5

99.0

3.13

7772

26612

(3009343) pH of Capillary blood

2875

6248

2.61

307.65

6.1

3.4

7.4

7.94

416

637

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

33394

149572

1.97

307.65

5.5

3.5

mmol/mol

39.2

37.1

224.44

31751

140316

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1453

2329

3.48

307.65

8.1

3.9

iu/ml

659.1

577.9

0.21

220

200

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2731

3227

4.85

307.65

3.8

2.3

95.6

93.0

4.95

2521

3007

(3012516) Albumin [Mass/volume] in Urine

10421

26399

2.52

307.65

3.8

2.9

mg/l

403.3

452.7

0.43

6995

15863

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2180

4455

2.75

307.65

1.6

1.5

u/ml

12.5

12.0

0.05

156

(3000991) Gas panel - Venous blood

3833

7514

2.95

307.65

12.5

6.5

—

(3036489) Thrombin time

2936

3633

4.65

307.65

3.0

2.1

21.3

20.6

6.08

2447

3149

(3027945) Reticulocytes/100 erythrocytes in Blood

4070

9614

2.44

307.65

3.5

2.8

1.8

1.6

21.76

3701

8588

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

36318

176021

1.80

307.65

4.3

3.1

mmol/l

1.4

1.5

253.11

34569

166048

(3018418) pH of Serum or Plasma

11781

33534

2.26

307.65

5.2

2.8

7.4

0.64

2504

5958

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2145

3804

3.18

307.65

13.0

8.4

mmol/l

24.1

24.2

0.49

2035

3619

(3027273) Bicarbonate [Moles/volume] in Venous blood

1864

3388

3.09

307.65

4.7

2.4

mmol/l

25.1

25.2

0.97

1796

3257

(3013650) Neutrophils [#/volume] in Blood by Automated count

23875

93358

1.89

307.65

10.4

8.2

e9/l

4.1

3.9

34.96

21239

81808

(42870588) Differential panel, method unspecified - Blood

14996

50203

1.96

307.65

7.1

5.8

—

(3023368) Bacteria identified in Blood by Culture

10197

26752

2.41

307.65

4.8

3.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

13160

42802

1.97

307.65

3.2

2.1

u/l

56.2

58.3

1.95

12307

39432

(3003396) Base excess in Arterial blood by calculation

4618

8010

3.40

307.65

9.4

6.1

mmol/l

0.8

0.7

1.03

3607

6000

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1565

1661

5.29

307.65

1.3

1.2

u/ml

4.1

3.0

0.85

535

603

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3129

6313

2.83

307.65

6.0

2.5

ng/l

96.1

60.6

52.73

2847

5616

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4500

10647

2.45

307.65

4.8

4.2

u/l

237.6

231.6

1.11

4296

10144

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

31346

138723

1.85

307.65

4.4

3.7

pmol/l

14.6

14.4

38.09

29441

127831

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

20800

69787

2.21

307.65

6.7

5.0

umol/l

10.8

0.01

19744

65398

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

16682

64439

1.67

307.65

2.7

2.1

nmol/l

73.0

1444.7

0.50

15654

59829

(3035350) Ketones [Presence] in Urine by Test strip

19695

80956

1.60

307.65

3.8

2.7

estimate

0.0

0.22

4014

14763

(3009508) Creatinine [Moles/volume] in Urine

12276

35662

2.23

307.65

3.9

2.9

mmol/l

8.0

9.1

1.92

10745

30787

(3013115) Eosinophils [#/volume] in Blood

22078

83435

1.91

307.65

7.6

5.8

e9/l

0.2

0.68

19888

74281

(3019060) Gas panel - Arterial blood

2540

4028

3.59

307.65

5.5

3.9

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

5217

10374

2.98

307.65

8.7

6.1

mmol/l

104.7

104.8

1.59

5109

10194

(3033658) Prothrombin time (PT) actual/Normal

11621

32884

2.27

307.65

5.0

3.0

93.3

97.1

47.53

11306

31984

(3023520) Reticulocytes [#/volume] in Blood

2959

6506

2.59

307.65

3.3

2.7

e9/l

72.7

68.3

5.79

2187

4741

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1233

1922

3.57

295.03

4.6

2.5

mmol/l

24.1

24.3

0.80

1107

1701

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

28107

130987

1.49

289.65

3.6

2.5

u/l

45.9

35.7

77.41

26839

124888

(40768797) Stomach Pathology biopsy report

5596

18008

1.80

288.78

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1808

3685

2.75

282.62

1.7

1.6

titre

466.8

334.5

0.59

132

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

15459

64327

1.48

278.94

3.8

2.7

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

910

1168

4.31

278.65

1.3

nmol/l

0.3

0.2

1.14

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3424

9456

2.06

275.89

2.9

2.0

ml/min/173m2

72.2

82.7

28.82

1341

3106

(40768446) Kidney Pathology biopsy report

428

221

10.65

275.01

2.0

1.3

—

(3047181) Lactate [Moles/volume] in Blood

1445

2629

3.06

274.21

6.4

3.8

mmol/l

1.2

0.53

1288

2278

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

908

1184

4.25

272.91

1.3

nmol/l

0.5

1.5

0.50

881

1146

(3043409) Potassium [Moles/volume] in Arterial blood

1192

1946

3.40

266.92

4.6

3.4

mmol/l

3.9

3.8

6.00

1117

1829

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

832

1029

4.47

265.78

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2475

6086

2.29

264.21

1.6

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2144

4961

2.43

261.24

1.7

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

280

26.93

255.81

6.6

6.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

9285

35151

1.56

255.78

3.8

2.8

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2252

5394

2.34

254.66

2.1

1.9

u/l

38.7

40.8

4.78

2035

5143

(3010421) pH of Blood

1295

2307

3.12

253.96

4.5

2.4

7.4

0.73

1115

1890

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

7977

29234

1.60

251.68

1.3

iu/ml

29.0

30.5

0.14

2428

9066

(3022313) Gas panel - Capillary blood

2041

4725

2.42

248.17

6.8

3.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6061

20780

1.69

247.67

2.8

2.6

mmol/l

2.4

7.03

5286

18196

(1616796) Gas panel - Central venous blood

1145

1916

3.32

247.12

4.3

2.1

—

(3021901) Oxygen saturation in Capillary blood

898

1283

3.87

241.08

3.6

2.2

—

(3027315) Oxygen [Partial pressure] in Blood

1138

1935

3.26

239.74

4.5

2.5

kpa

9.0

9.3

2.40

1120

1890

(3013290) Carbon dioxide [Partial pressure] in Blood

1132

1935

3.25

236.55

4.5

2.5

kpa

5.0

0.03

1114

1890

(3010375) cycloSPORINE [Mass/volume] in Blood

447

316

7.78

236.11

29.6

21.7

ug/l

121.1

136.7

1.52

370

275

(3012501) Base excess in Blood by calculation

1131

1935

3.24

236.02

4.5

2.5

mmol/l

2.2

2.0

1.24

732

1178

(3029937) Albumin [Presence] in Urine by Test strip

10689

42385

1.50

234.63

4.2

2.9

estimate

0.0

0.59

4013

15082

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1196

2130

3.12

234.50

1.8

1.7

—

(3039000) Anion gap in Blood

990

1553

3.53

234.47

7.7

5.2

mmol/l

11.3

0.08

898

1378

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1217

2192

3.08

234.37

1.8

1.6

—

(3018572) Chloride [Moles/volume] in Blood

990

1554

3.53

234.26

7.7

5.2

mmol/l

105.4

105.5

0.20

898

1379

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

536

483

6.11

234.12

1.2

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

3731

11238

1.89

233.82

4.6

4.1

0.8

0.9

0.66

1075

2458

(40767503) Oxygen content in Capillary blood by calculation

1041

1709

3.38

231.00

2.8

1.8

17.1

17.7

4.05

566

820

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1528

3189

2.67

227.95

2.2

1.9

mg/l

11.0

9.6

5.85

1426

3043

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

7481

27574

1.58

227.52

1.3

u/ml

8.2

10.1

1.97

3058

11584

(40760892) CBC W Ordered Manual Differential panel - Blood

10257

40597

1.49

225.52

5.0

3.8

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

505

448

6.20

223.56

1.1

1.0

94.2

94.5

0.06

421

342

(3023183) Ammonium ion [Moles/volume] in Plasma

1059

1802

3.26

222.75

3.5

2.5

umol/l

35.6

33.2

1.43

932

1547

(3007164) IgA [Mass/volume] in Serum or Plasma

9783

38467

1.50

221.31

1.5

1.4

g/l

2.3

2.1

14.55

6472

24162

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

644

754

4.71

218.45

1.2

1.1

ratio

1.1

0.77

228

288

(3024932) HLA-DR beta [Type]

372

225

9.08

217.95

1.1

1.3

—

(3024471) HLA-A [Type]

376

236

8.75

215.20

1.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2296

6000

2.15

211.09

1.3

1.2

u/ml

1.0

0.7

0.56

202

441

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4051

12926

1.78

210.42

3.0

2.1

u/l

49.1

41.5

0.27

3523

11101

(3002179) Metamyelocytes/100 leukocytes in Blood

3420

10373

1.86

208.75

4.3

3.9

0.5

0.6

0.43

776

1831

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

660

826

4.40

207.91

8.1

5.3

mg/l

10.6

9.8

3.28

613

759

(3021440) Promyelocytes/100 leukocytes in Blood

3532

10844

1.84

207.56

4.7

4.2

0.1

1.17

992

2277

(3007461) Platelets [#/volume] in Blood

41597

217320

2.36

205.46

23.1

11.7

e9/l

259.5

259.9

0.63

41010

211301

(3028626) Oxygen [Partial pressure] in Capillary blood

1378

2883

2.66

204.38

7.9

4.6

kpa

9.0

9.2

3.40

1308

2717

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1560

3527

2.46

198.55

1.9

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1376

2923

2.62

198.20

1.5

1.3

iu/ml

9.4

13.7

0.62

(3035941) MCH [Entitic mass]

41607

217652

2.33

196.88

23.0

11.7

30.1

4.52

41331

214688

(3024731) MCV [Entitic volume]

41610

217679

2.33

196.73

23.0

11.7

90.1

89.9

33.62

41337

214697

(3026361) Erythrocytes [#/volume] in Blood

41612

217723

2.33

195.77

23.1

11.7

e12/l

4.6

53.11

40954

211266

(3034426) Prothrombin time (PT)

380

280

7.45

194.84

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1849

4567

2.26

194.08

2.3

1.8

—

(3010813) Leukocytes [#/volume] in Blood

41614

217800

2.32

193.71

23.2

11.8

e9/l

6.8

6.6

92.71

40968

211294

(3019150) Specific gravity of Urine by Refractometry

8862

34962

1.48

192.92

4.0

2.8

kg/l

1.0

0.67

1260

5148

(3025159) Blasts/100 leukocytes in Blood

3364

10404

1.83

192.53

4.7

4.2

0.1

0.2

0.11

845

1947

(3000963) Hemoglobin [Mass/volume] in Blood

41615

217855

2.31

192.14

23.3

11.8

g/l

136.5

137.9

68.99

41336

214890

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1539

3534

2.42

189.53

1.9

1.2

u/ml

18.1

22.4

0.48

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

939

1641

3.16

189.43

3.3

3.2

mg/l

42.5

30.1

1.02

748

1349

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1474

3316

2.47

189.42

1.9

1.2

u/ml

107.7

103.9

0.46

331

699

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

11024

45505

1.43

188.90

1.3

u/ml

1.5

1.8

2.02

3132

12833

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

914

1576

3.21

188.25

3.2

ratio

2.0

2.3

0.13

159

(3034860) Kappa light chains.free [Mass/volume] in Serum

937

1645

3.15

187.67

3.3

3.2

mg/l

58.4

32.8

2.49

744

1347

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1125

2213

2.82

186.53

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1565

3659

2.38

185.45

1.6

1.2

u/ml

242.8

235.0

0.50

1068

2240

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

512

570

4.94

183.14

1.2

1.1

u/ml

23.1

4.4

1.43

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1803

4518

2.23

182.84

6.9

3.8

mmol/l

24.6

24.4

2.64

1720

4317

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1327

2887

2.55

182.33

1.9

1.5

—

(3028271) Lactate [Moles/volume] in Capillary blood

791

1269

3.44

181.31

2.0

1.6

mmol/l

1.7

1.8

1.77

771

1241

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1627

3914

2.31

181.09

1.6

1.2

—

(40761535) Cells panel - Urine sediment

3029

9250

1.84

179.92

3.9

2.6

—

(3000494) Fungus identified in Specimen by Culture

4873

17045

1.63

179.63

1.6

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1005

1910

2.91

176.82

4.8

1.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

11424

47984

1.40

174.79

3.3

2.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

866

1527

3.13

172.22

1.8

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1224

2636

2.57

171.47

2.2

1.9

g/l

3.8

0.75

928

1891

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3360

10752

1.76

171.08

3.3

3.4

pmol/l

4.5

4.7

7.29

3026

9725

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1224

2640

2.57

170.96

2.2

1.9

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1224

2641

2.57

170.84

2.2

1.9

g/l

7.3

7.0

5.19

964

2048

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

934

1747

2.95

168.77

2.8

2.2

ug/min

197.2

36.3

9.74

621

1093

(3011648) Oxygen content in Venous blood

508

619

4.51

164.93

5.4

6.3

11.2

11.6

1.12

508

619

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1171

2541

2.55

161.56

2.3

1.9

g/l

3.1

2.9

4.75

947

1995

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1135

2436

2.58

159.99

2.3

1.9

g/l

10.5

10.3

0.34

993

2072

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4301

15000

1.62

159.10

6.5

3.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

847

1548

3.02

158.99

1.6

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

186

20.35

157.31

8.7

5.6

—

(4094501)

1186

2634

2.49

156.18

1.1

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

723

1209

3.30

155.93

3.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

721

1207

3.29

155.24

1.7

1.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

955

1901

2.78

154.90

1.3

1.2

titre

244.2

135.3

0.35

(3022145) Colonoscopy Study observation

4581

16347

1.59

154.02

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

6563

25356

1.48

153.91

2.7

2.6

ug/g

119.6

117.9

0.15

5283

20040

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

830

1531

2.99

153.45

1.4

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

184

18.30

150.30

5.5

5.3

mg/l

2.2

2.5

0.36

160

(3038071) Oxygen [Partial pressure] in Mixed venous blood

174

21.14

148.93

8.8

5.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

983

2035

2.67

148.38

2.2

1.8

g/l

0.0

0.01

923

1895

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1055

2268

2.57

148.17

2.3

2.0

g/l

0.5

0.6

0.33

956

2008

(3017143) Hepatitis C virus Ab [Presence] in Serum

7092

28028

1.45

147.56

1.8

1.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

906

1802

2.78

147.14

2.3

1.8

g/l

0.0

0.00

851

1687

(3034770) Mitochondria Ab [Titer] in Serum

1522

3892

2.17

146.59

1.3

titre

882.3

978.7

0.18

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

909

1824

2.75

145.30

2.3

1.8

g/l

0.0

0.00

852

1689

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

708

1232

3.17

143.70

1.5

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

972

2038

2.63

143.22

2.2

1.7

g/l

38.1

39.9

12.52

877

1786

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

783

1475

2.93

139.74

1.7

1.5

—

(3037121) Protein [Mass/volume] in Urine

1539

4033

2.12

139.46

4.3

3.2

g/l

0.4

0.3

3.13

833

1812

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1115

2542

2.43

139.01

2.6

2.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

1543

4065

2.11

137.94

1.3

titre

99.9

141.6

1.09

159

377

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

607

980

3.41

137.85

1.5

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

365

386

5.19

137.58

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

639

1070

3.29

137.53

1.9

1.6

90.9

91.4

1.16

628

1052

(3052851) Hemolysis interference index of Serum or Plasma

1342

3352

2.22

136.61

3.2

2.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1005

2218

2.50

133.92

2.5

1.8

g/l

133.1

135.7

2.38

782

1633

(44806118)

655

1136

3.17

133.63

1.8

1.5

—

(44790048)

655

1137

3.17

133.44

1.8

1.5

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

556

864

3.54

133.31

3.2

2.0

95.2

101.9

3.75

515

791

(44790049)

654

1136

3.17

133.11

1.8

1.5

—

(44790047)

654

1137

3.17

132.92

1.8

1.5

—

(40768804) Tissue Pathology biopsy report

15059

68197

1.31

132.39

2.0

1.9

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2058

6162

1.86

128.68

3.2

2.0

e6/l

0.3

0.2

0.10

1988

5936

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

598

1011

3.25

126.87

1.5

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1257

3156

2.20

126.32

1.4

1.3

ug/g

290.3

307.2

1.70

678

1662

(3048929) Epstein Barr virus Ab [Presence] in Serum

2494

7985

1.74

125.32

1.5

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

596

1014

3.23

125.24

1.8

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1463

3927

2.07

124.51

1.5

1.4

mg/l

472.2

467.9

0.07

1402

3754

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

117

58.09

122.44

7.5

4.5

mmol/l

6.4

5.5

0.84

117

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

807

1683

2.64

120.07

1.7

1.6

—

(3037756) Immunofixation for Serum or Plasma

620

1114

3.06

119.62

1.6

1.9

—

(3003181) Sodium [Moles/volume] in Urine

620

1115

3.06

119.45

1.6

1.7

mmol/l

67.3

71.0

0.83

510

856

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1541

4292

1.99

118.75

1.3

1.2

u/ml

29.9

33.0

0.18

257

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

638

1190

2.95

115.78

1.5

1.4

—

(3019225) pH of Specimen

3285

11551

1.59

115.55

4.6

2.8

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1308

3469

2.09

114.74

1.6

1.5

e6/l

4529.4

569.6

0.78

1065

2753

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1306

3464

2.09

114.54

1.6

1.4

e6/l

23.7

21.2

0.15

1020

2620

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1423

3909

2.02

113.80

1.3

u/ml

12.5

9.9

0.46

225

550

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1299

3455

2.08

113.11

1.4

mmol/l

3.7

3.5

6.10

1225

3256

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1403

3846

2.02

112.83

1.3

u/ml

8.5

7.6

0.10

144

364

(3005322) IgE [Units/volume] in Serum or Plasma

3495

12539

1.56

112.79

1.4

1.3

u/ml

215.3

261.6

1.31

3274

11628

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

336

398

4.63

112.65

1.2

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

659

1275

2.84

112.35

1.3

nmol/l

26.3

29.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1132

2892

2.16

108.99

1.2

u/ml

33.9

14.9

0.70

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1009

2463

2.26

108.18

4.3

1.7

nmol/l

0.9

0.7

10.01

852

2136

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1153

2984

2.14

107.53

1.3

1.2

u/ml

6.3

4.3

0.29

214

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

593

1129

2.89

103.96

1.1

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

1233

3320

2.05

103.92

1.6

1.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

372

520

3.92

102.73

2.1

2.0

g/24h

1.0

1.3

0.32

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

598

1155

2.85

102.27

1.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

889

2105

2.33

102.06

1.2

1.3

—

(3006576) Bicarbonate [Moles/volume] in Blood

199

149

7.30

101.00

7.5

3.2

mmol/l

24.9

24.1

1.17

189

141

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

895

2138

2.31

100.75

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

894

2137

2.31

100.49

1.3

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

711

1527

2.56

99.98

3.2

1.9

mmol/l

1.5

1.4

0.84

695

1491

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

534

988

2.97

98.26

1.4

umol/l

11.4

10.0

5.25

515

928

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

626

1274

2.70

97.51

1.3

u/l

34.3

31.1

0.17

545

1109

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

744

1658

2.47

97.16

1.7

1.5

—

(3004451) EKG impression Narrative

196

153

7.01

96.42

1.3

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

529

990

2.93

95.51

1.8

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

937

2339

2.21

95.34

2.5

2.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

962

2431

2.18

95.06

1.6

g/l

0.7

0.22

710

1898

(3035637) Corticotropin [Mass/volume] in Plasma

771

1780

2.38

93.51

1.8

1.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3284

12107

1.52

92.97

2.4

2.3

au/ml

21.2

21.0

0.02

184

1045

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

102

26.52

92.97

7.2

8.9

—

(4010399)

2684

9454

1.58

92.96

1.4

—

(4035726)

3100

11321

1.53

91.61

1.5

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1213

3403

1.97

91.40

1.3

1.2

u/ml

41.8

0.00

122

269

(3004775) Volume in Urine collected for unspecified duration

339

484

3.84

91.18

2.5

2.0

701.1

587.5

4.18

263

357

(3016750) Collection duration of Urine

290

369

4.30

89.80

2.5

1.9

min

501.1

507.8

0.48

235

293

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3042

11132

1.53

88.95

1.3

au/ml

47.4

48.3

0.06

100

487

(3038515) Glucose [Moles/volume] in Venous blood

649

1413

2.52

88.85

3.2

2.0

mmol/l

7.6

7.0

2.46

634

1389

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

251

287

4.79

87.51

3.1

2.4

—

(3025941) Bacteria identified in Stool by Culture

2889

10495

1.54

87.28

1.3

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

376

612

3.37

84.53

1.2

1.3

—

(40761536) Microorganisms panel - Urine sediment

3695

14214

1.46

84.50

4.3

2.8

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

231

253

4.99

84.24

1.2

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

4482

17929

1.40

82.69

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

384

645

3.26

82.40

1.2

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2787

10190

1.52

81.56

3.9

4.1

ug/l

21.2

25.9

0.28

2115

7593

(3039162) Centromere protein B Ab [Units/volume] in Serum

758

1849

2.26

81.39

1.3

1.2

u/ml

51.7

44.9

0.26

104

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

159

118

7.36

81.31

1.3

1.2

pmol/l

397.6

360.9

0.13

114

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

567

1216

2.56

80.01

1.7

1.4

—

(3023419) Bacteria identified in Sputum by Culture

466

904

2.83

79.18

2.8

2.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1048

2939

1.97

79.01

1.1

—

(3012565) Volume of 24 hour Urine

293

421

3.81

78.23

2.2

2.1

1943.3

2138.7

1.74

281

393

(3003434) Protein [Mass/volume] in Pleural fluid

327

510

3.51

78.18

1.5

1.3

g/l

34.5

39.5

7.18

296

475

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1513

4808

1.74

77.31

2.1

1.8

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

282

398

3.88

77.06

8.8

1.5

mg/l

1189.4

5705.0

1.71

231

249

(3003694) ABO and Rh group [Type] in Blood

12657

58928

1.24

76.66

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

381

669

3.12

76.40

2.3

1.7

—

(4062490)

653

1534

2.34

76.32

1.4

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7672

33676

1.29

75.92

3.7

3.9

ug/l

1.8

2.5

6.31

6988

30939

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

348

580

3.29

75.60

1.6

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

131

8.73

75.31

7.9

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

516

1088

2.60

75.27

5.5

2.6

mmol/l

7.1

6.8

0.51

441

866

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

6581

28329

1.31

75.15

2.0

1.7

1.5

1.3

32.10

5888

25833

(3027135) IgG subclass 1 [Mass/volume] in Serum

647

1534

2.32

74.10

1.4

1.3

g/l

6.8

6.6

0.36

442

1098

(3028192) IgG subclass 2 [Mass/volume] in Serum

647

1535

2.32

73.99

1.4

1.3

g/l

2.9

3.0

0.98

444

1098

(3024139) IgG subclass 3 [Mass/volume] in Serum

646

1534

2.31

73.73

1.4

1.3

g/l

0.4

0.44

440

1099

(3009542) Hematocrit [Volume Fraction] of Blood

35832

186290

1.29

73.04

16.8

8.6

40.3

40.7

19.79

28524

154720

(3004809) Band form neutrophils/100 leukocytes in Blood

663

1607

2.27

72.27

3.3

2.8

1.3

1.4

0.40

536

1236

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

404

763

2.90

71.94

1.6

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

404

763

2.90

71.94

1.6

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

404

763

2.90

71.94

1.6

1.8

—

(21491868) Cryoglobulin [Mass/volume] in Serum

251

342

4.02

71.72

1.2

g/l

0.1

0.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1370

4323

1.75

71.67

1.9

1.7

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

409

783

2.86

71.16

1.7

1.9

140.1

112.9

10.36

382

750

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

515

1126

2.51

69.99

2.4

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

131

7.69

69.23

5.7

3.8

ug/min

42.6

28.6

0.93

(21494890) Protein electrophoresis panel - 24 hour Urine

314

520

3.31

68.91

2.2

2.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

331

568

3.19

68.84

1.6

nmol/l

3.1

2.9

0.05

274

456

(3011412) CD3 cells [#/volume] in Blood

634

1541

2.26

68.68

2.4

2.8

e9/l

1.3

0.29

401

882

(3003338) MCHC [Mass/volume]

33578

173574

1.25

67.79

19.6

9.9

g/l

333.3

333.8

13.96

33409

172142

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

320

543

3.23

67.72

1.8

1.6

—

(3051651) Icteric interference index of Serum or Plasma

338

597

3.10

67.21

4.1

3.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

440

906

2.66

67.19

1.4

nmol/l

1.5

1.3

3.96

390

830

(3042111) Morphology [Interpretation] in Bone marrow Narrative

555

1292

2.36

66.21

1.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

973

2839

1.89

65.39

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

941

2725

1.90

64.67

1.5

1.4

—

(3017732) Neutrophils [#/volume] in Blood

3006

11693

1.43

63.99

2.6

2.3

e9/l

4.2

4.0

3.07

2491

9706

(3023199) Leukocytes [#/volume] in Pleural fluid

300

510

3.22

63.34

1.5

1.3

e6/l

3613.6

4246.8

0.32

209

371

(3023420) DNA double strand Ab [Units/volume] in Serum

656

1682

2.14

62.62

1.8

1.6

iu/ml

40.9

33.9

0.37

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1635

5616

1.61

62.31

1.6

iu/ml

10.0

1.4

0.43

345

1067

(3019977) pH of Arterial blood

230

330

3.81

61.64

3.1

2.4

7.4

1.00

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

634

1614

2.16

61.60

1.3

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

512

1194

2.35

60.88

1.2

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

862

2474

1.92

60.83

1.7

1.6

e6/l

12611.1

10149.7

0.75

626

1829

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

513

1198

2.35

60.82

1.2

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

202

264

4.18

60.79

2.2

2.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

512

1195

2.35

60.77

1.2

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

10.92

60.34

5.3

4.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

517

1218

2.33

60.13

1.2

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

1008

3057

1.82

60.11

2.1

2.0

titre

5.3

7.7

0.40

116

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

516

1215

2.33

60.08

1.2

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

461

1030

2.45

60.03

3.7

2.7

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

516

1216

2.33

59.98

1.2

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

152

155

5.36

59.62

2.6

2.4

mg/l

39.3

26.6

0.39

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

950

2838

1.84

59.41

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

722

1965

2.02

59.13

1.1

g/l

1.5

1.4

7.70

666

1787

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

10.91

59.03

5.1

4.4

—

(3000034) Microalbumin [Mass/volume] in Urine

402

846

2.60

58.97

3.3

2.5

mg/l

105.0

43.2

2.02

310

573

(1175426) CD3 cells/100 lymphocytes in Blood

530

1276

2.28

58.74

2.3

2.4

72.3

73.9

1.19

516

1247

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1642

5729

1.58

58.63

2.3

2.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

14.49

57.71

7.2

4.7

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

159

176

4.94

57.51

2.5

1.5

e6/l

665.6

1443.5

1.57

112

(3008295) Osmolality of Serum or Plasma

454

1029

2.42

57.40

1.5

1.8

mosm/kgh2o

283.8

284.7

0.31

365

827

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

32.73

57.33

3.5

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

523

1266

2.27

57.26

2.3

2.4

11.9

12.4

0.32

309

706

(36660697) Celiac disease serology panel - Serum

3970

16473

1.34

57.11

1.2

—

(3044927) Protein electrophoresis panel - Urine

286

505

3.10

56.99

1.1

—

(3042631) Mycobacterium sp identified in Specimen

432

961

2.46

56.79

2.4

2.5

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

498

1186

2.30

56.58

1.1

u/ml

58.7

77.6

0.39

(37021550) Renin [Units/volume] in Plasma --upright

138

135

5.58

56.31

1.5

1.6

mu/l

138.9

70.6

0.69

110

117

(3013139) Helicobacter pylori Ag [Presence] in Stool

2863

11299

1.41

55.97

1.2

—

(3012441) Differential panel - Pleural fluid

264

448

3.22

55.96

1.5

1.3

—

(3045788) Cell count panel - Pleural fluid

242

395

3.35

54.38

1.5

1.4

—

(3002256) Pathology report gross observation

4718

20204

1.31

54.31

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

286

521

3.00

54.22

1.7

2.1

nmol/l

1.3

0.23

222

429

(3016018) Differential panel - Cerebral spinal fluid

660

1798

2.02

53.95

1.6

1.5

—

(3049717) Cytology report of Urine Cyto stain

949

2925

1.78

53.70

2.2

2.5

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

300

566

2.90

53.66

1.7

1.9

163.4

122.1

9.68

280

531

(1002224) Polysomnography panel

2277

8683

1.45

53.61

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

376

805

2.56

53.40

2.7

2.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1393

4777

1.61

53.38

1.2

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

121

109

6.06

53.17

1.5

1.2

g/l

12.8

13.1

0.09

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1382

4735

1.61

53.15

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

260

452

3.15

53.13

1.5

1.4

—

(3034988) Calcium [Moles/volume] in Capillary blood

141

150

5.13

53.13

5.1

3.8

mmol/l

1.2

0.35

136

138

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

234

381

3.36

52.79

1.9

1.6

u/ml

20377.1

1400.5

0.51

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

15.06

52.55

11.2

3.2

—

(3016038) Potassium [Moles/volume] in Urine

266

473

3.08

52.46

1.6

1.9

mmol/l

33.9

36.5

0.74

246

421

(42529406) Shigella sp [Presence] in Stool by Culture

1395

4806

1.60

52.45

1.2

1.1

—

(3036603) Volume of Urine

322

641

2.75

52.44

1.6

2099.3

2056.5

0.11

(3000492) Spirometry study

4284

18192

1.31

52.28

1.4

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

135

140

5.27

52.16

4.4

3.5

mmol/l

1.2

0.85

129

128

(3028308) Erythrocytes [#/volume] in Pleural fluid

263

467

3.08

51.99

1.5

1.3

e6/l

37542.5

56289.2

0.66

148

284

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

300

577

2.84

51.93

1.1

94.5

95.3

0.14

146

249

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

470

1134

2.27

51.89

1.2

titre

110.0

201.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3744

15611

1.34

51.87

1.2

iu/ml

137.5

149.6

0.86

1405

6118

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

477

1161

2.25

51.63

1.3

1.2

mmol/l

2.0

1.8

2.15

446

1081

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

886

2707

1.80

51.61

1.1

iu/ml

1307.3

3927.8

0.37

211

730

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

304

592

2.81

51.50

1.2

107.5

112.4

0.95

269

531

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

470

1138

2.26

51.48

1.2

titre

272.9

187.3

0.95

189

(3016244) Insulin [Units/volume] in Serum or Plasma

566

1490

2.08

50.65

3.5

3.3

mu/l

25.3

27.0

0.47

537

1393

(3017569) Oxygen content in Arterial blood

172

230

4.09

50.45

2.3

2.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

996

3173

1.73

50.38

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

534

1379

2.12

50.17

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

224

367

3.34

50.11

1.4

1.2

u/l

390.3

883.1

3.47

212

348

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

452

1089

2.27

50.09

1.2

u/l

81.6

73.2

0.28

340

718

(3020191) Ethanol [Moles/volume] in Serum or Plasma

533

1378

2.12

49.94

1.7

1.5

promille

1.3

1.5

2.04

398

1069

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

140

159

4.81

49.38

2.3

1.4

e6/l

17825.0

14555.0

0.07

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

351

756

2.54

49.31

1.5

1.4

u/l

6.0

5.3

0.83

301

644

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1158

3867

1.65

49.28

1.5

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

118

115

5.60

48.38

4.1

3.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

5222

22984

1.27

48.13

1.8

2.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1061

3486

1.67

48.01

3.5

3.7

u/ml

1670.8

711.3

0.49

916

3013

(44806071)

133

148

4.91

47.93

1.1

—

(3023410) Appearance of Cerebral spinal fluid

623

1744

1.96

47.30

1.9

1.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

346

758

2.50

47.02

1.7

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

232

407

3.12

46.81

1.6

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

771

2326

1.82

46.80

1.1

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

286

569

2.75

46.70

1.2

1.1

92.4

99.2

1.63

140

246

(3036782) Glucose [Moles/volume] in Pleural fluid

265

505

2.87

46.67

1.4

1.2

mmol/l

6.2

5.4

3.97

241

453

(3000093) Morphology [Interpretation] in Blood Narrative

404

956

2.31

46.65

1.2

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

476

1209

2.16

46.63

2.5

3.0

e9/l

0.2

2.08

394

1012

(40768441) Liver Pathology biopsy report

402

954

2.31

46.13

1.6

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

480

1229

2.14

46.11

2.5

3.0

e6/l

515.5

536.1

0.32

390

1015

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

232

411

3.09

46.10

1.6

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1506

5442

1.53

46.02

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1773

6630

1.48

46.01

1.6

1.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

957

3093

1.70

46.01

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

350

780

2.46

45.95

1.2

1.1

—

(3019174) dRVVT (LA screen)

107

100

5.84

45.59

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

244

451

2.96

45.27

1.6

1.4

u/l

12.0

10.9

1.29

236

443

(21494815) CD4 cells/100 lymphocytes in Specimen

544

1479

2.02

44.79

2.3

2.5

43.0

43.9

0.18

199

(3004616) Nuclear Ab [Presence] in Serum

603

1704

1.94

44.60

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1612

5955

1.49

44.39

1.4

1.3

—

(3044007) Cell count panel - Peritoneal fluid

128

148

4.72

44.35

2.3

1.5

—

(40768806) Pleura Pathology biopsy report

250

475

2.88

44.29

1.6

1.4

—

(3000330) Specific gravity of Urine by Test strip

1577

5803

1.50

44.25

3.4

2.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

476

1236

2.11

44.18

3.0

3.1

nmol/l

4.9

7.5

0.26

456

1204

(3033799) Differential panel - Peritoneal fluid

130

154

4.61

43.89

2.0

1.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

235

433

2.97

43.84

2.8

2.3

umol/l

28.7

95.5

4.97

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3311

13886

1.32

43.73

2.4

2.1

nmol/l

11.9

12.7

7.13

2988

12605

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

350

800

2.39

43.61

2.5

2.9

43.0

40.0

1.46

130

237

(3044941) Cell count panel - Synovial fluid

575

1613

1.95

43.44

1.5

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1258

4433

1.56

42.99

1.9

2.0

iu/l

4.5

23.9

0.96

471

1847

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

317

696

2.49

42.94

2.1

2.6

umol/l

145.1

165.3

0.39

142

363

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

320

706

2.48

42.92

2.5

3.2

nmol/l

98.1

93.2

0.09

311

694

(3033923) Metanephrine [Moles/time] in 24 hour Urine

121

137

4.82

42.88

1.1

umol/24h

0.7

0.6

0.66

(21494755) Public health laboratory ask at order entry panel

4772

31698

0.80

42.17

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

107

109

5.36

42.14

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1382

5002

1.52

41.91

1.2

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

10782

51701

1.18

41.91

1.8

1.6

—

(3022621) pH of Urine by Test strip

2398

9641

1.38

41.67

2.8

2.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2032

7943

1.41

41.65

1.1

u/ml

26.1

9.7

0.52

102

(4034850)

1287

4592

1.54

41.64

9.9

5.8

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

280

588

2.60

41.42

1.2

u/l

96.5

87.1

0.39

252

511

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

335

769

2.38

41.40

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

608

1770

1.88

41.26

1.1

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3198

22236

0.77

41.22

1.5

—

(3006245) CD3-CD19+ cells/100 cells in Blood

339

785

2.36

41.12

2.6

13.9

10.3

3.25

326

755

(3045414) Leukocytes [Presence] in Urine

1763

6731

1.44

41.08

1.9

1.6

—

(3045142) Bone marrow Pathology biopsy report

407

1022

2.18

41.06

1.4

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

12.65

41.00

1.3

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

274

574

2.61

40.73

1.2

u/l

21.5

17.8

0.56

246

491

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

398

994

2.19

40.68

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5943

27016

1.23

40.56

3.3

21.5

20.8

1.88

2171

10714

(3017704) Immunofixation for Urine

177

286

3.38

40.51

1.4

1.9

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

582

1682

1.90

40.38

1.2

1.1

mg/l

35.1

41.7

2.73

506

1393

(3013005) Retinol [Moles/volume] in Serum or Plasma

355

848

2.29

40.23

2.5

2.2

umol/l

1.9

1.8

1.27

336

800

(3003327) Ova and parasites identified in Stool by Light microscopy

1831

7076

1.43

39.96

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

332

775

2.34

39.60

1.2

1.1

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

199

353

3.08

39.55

1.5

1.2

103.7

104.2

0.07

186

332

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

566

1632

1.90

39.54

1.1

mg/l

230.9

238.4

0.30

511

1433

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3899

16935

1.28

39.48

4.0

3.2

31.4

31.5

0.31

3012

11746

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

450

1202

2.05

38.91

1.1

mg/l

292.2

286.3

0.64

406

1100

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

555

1603

1.90

38.60

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1163

4131

1.55

38.40

1.9

1.8

pmol/l

187.9

199.2

2.71

1104

3975

(3037692) Legionella sp identified in Specimen by Organism specific culture

168

272

3.37

38.37

1.5

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

599

1782

1.84

38.08

2.4

2.5

nmol/l

22.2

21.2

1.03

570

1724

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

312

721

2.37

38.06

1.8

mg/l

3.9

2.5

5.08

303

681

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

189

333

3.10

37.99

1.1

79.6

93.4

1.85

(3045716) Anion gap in Serum or Plasma

191

339

3.08

37.95

3.2

2.0

mmol/l

9.6

9.3

0.43

143

251

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

9581

45806

1.18

37.82

1.8

1.7

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

318

749

2.32

37.23

2.4

2.5

26.8

28.9

2.03

309

724

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

245

508

2.64

37.19

1.8

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

244

506

2.64

37.03

1.8

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

244

506

2.64

37.03

1.8

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

244

506

2.64

37.03

1.8

2.1

—

(21494434) Karyotype in Bone marrow

306

710

2.36

37.02

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

133

188

3.86

36.56

2.0

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

143

214

3.65

36.48

3.4

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

143

214

3.65

36.48

3.4

2.4

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

251

533

2.57

36.42

1.1

iu/ml

4.3

3.5

0.66

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

171

291

3.21

36.30

1.3

1.2

u/l

12.2

19.6

5.81

158

278

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

405

1069

2.07

36.16

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

243

510

2.60

36.07

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

186

337

3.02

35.78

1.1

72.7

76.0

0.21

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

406

1078

2.06

35.70

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

436

1192

2.00

35.48

3.7

3.1

—

(3008898) HLA-B27 [Presence]

2065

8328

1.37

35.11

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

181

327

3.02

35.00

2.4

1.5

—

(3021788) Differential panel - Synovial fluid

651

2043

1.75

34.81

1.6

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

773

2545

1.67

34.80

5.5

umol/l

372.8

385.9

1.31

683

2237

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

317

772

2.25

34.47

1.4

1.2

72.6

75.8

0.23

(3006922) Hepatitis E virus Ab [Presence] in Serum

430

1185

1.99

34.26

1.1

—

(3035880) pH of Pleural fluid

137

209

3.58

34.09

1.3

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

103

125

4.50

33.97

1.5

1.2

55.8

54.2

0.13

110

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

597

1845

1.77

33.64

3.3

3.2

u/ml

246.7

502.9

0.41

569

1652

(40768443) Skin Pathology biopsy report

1586

6179

1.41

33.06

1.2

—

(4027681)

463

1332

1.90

32.66

1.2

1.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

304

745

2.23

32.61

2.6

2.3

umol/l

27.5

28.3

0.60

299

718

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

264

610

2.37

32.31

1.2

g/l

0.3

0.76

216

476

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

206

421

2.67

32.21

2.0

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

206

421

2.67

32.21

2.0

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1897

7656

1.37

32.08

1.4

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

121

4.42

31.74

2.3

1.9

ug/g

175.4

162.6

0.28

104

(3017354) Segmented neutrophils/100 leukocytes in Blood

369

990

2.04

31.65

3.0

2.9

57.8

54.3

1.87

248

623

(3010503) CD19 cells [#/volume] in Blood

324

826

2.15

31.65

2.4

3.1

e9/l

0.3

0.2

0.34

317

819

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

303

753

2.20

31.48

1.8

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

569

1774

1.76

31.17

3.6

u/ml

799.7

365.8

0.46

528

1610

(3020961) Endomysium IgA Ab [Titer] in Serum

2525

10677

1.31

31.12

1.1

titre

150.2

208.3

0.58

335

(4146454)

324

833

2.13

31.01

2.8

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

104

4.67

30.63

1.4

1.2

2.9

4.8

0.77

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3443

15178

1.26

30.47

2.4

u/l

5737.5

6515.6

0.70

1198

6294

(3025315) Body weight

7.53

30.39

3.9

1.6

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

4.83

30.33

1.4

1.2

31.5

30.0

0.13

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

370

1012

2.00

30.16

1.2

u/ml

42.7

44.4

0.05

(3023323) Follitropin [Units/volume] in Serum or Plasma

3189

13951

1.26

30.10

1.4

1.3

iu/l

23.2

24.2

1.01

2722

11953

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

245

566

2.37

30.04

1.2

112.0

108.7

1.07

219

509

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1247

9534

0.70

30.01

1.5

—

(3038026) Centromere Ab [Units/volume] in Serum

376

1037

1.98

29.97

1.2

u/ml

38.1

48.7

0.26

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

369

1011

2.00

29.95

1.2

u/ml

71.6

56.3

0.34

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1720

12486

0.74

29.84

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1588

11664

0.73

29.80

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

218

478

2.49

29.80

1.2

1.1

—

(3005033) Fetal Nuchal fold Thickness US

1247

9513

0.71

29.62

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

226

506

2.44

29.61

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1601

11713

0.73

29.26

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1602

11719

0.73

29.26

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1598

11691

0.73

29.21

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

709

2391

1.63

29.17

3.9

2.6

—

(3047189) Immunofixation for 24 hour Urine

139

239

3.17

29.16

1.7

2.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

8.79

29.07

6.3

3.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1289

9724

0.71

28.63

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

221

498

2.42

28.59

1.3

1.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

355

976

1.99

28.57

1.2

u/ml

18.3

9.2

0.41

(3009214) Lutropin [Units/volume] in Serum or Plasma

2002

8295

1.33

28.47

1.5

1.4

u/l

8.7

0.00

1646

6750

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

194

412

2.57

28.28

3.6

2.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

425

1248

1.86

28.28

2.6

3.0

e6/l

751.4

803.9

0.64

153

476

(3045462) Protein/Creatinine [Ratio] in Urine

141

250

3.08

28.21

6.2

5.7

g/mol

126.4

237.8

0.24

132

231

(46235355) HIV 1 and 2 tests - Meaningful Use set

11637

57454

1.14

28.18

2.1

2.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1870

7683

1.34

28.16

1.4

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

384

1092

1.92

28.11

1.1

u/l

1.0

0.03

176

470

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

260

637

2.23

28.00

2.7

umol/l

53.2

50.5

0.76

225

579

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

299

778

2.10

27.83

4.5

4.6

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

276

698

2.16

27.57

3.0

1.5

ug/l

130.2

330.3

0.59

260

663

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

15.10

27.47

1.3

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

38.19

27.34

3.7

2.7

—

(3000060) B lymphocytes [#/volume] in Blood

264

665

2.17

26.65

2.6

2.5

e6/l

227.5

236.5

0.11

155

385

(3010144) Erythrocytes [#/volume] in Synovial fluid

339

942

1.97

26.53

1.5

1.4

e6/l

93110.8

37808.8

0.93

240

644

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

305

817

2.04

26.37

1.1

nmol/l

3.0

4.0

0.19

154

(3028707) Methadone [Presence] in Urine by Screen method

1513

6080

1.37

26.28

3.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

173

361

2.62

26.13

2.1

—

(4198724)

463

1434

1.77

26.03

2.7

2.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

186

405

2.51

25.87

1.9

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

186

405

2.51

25.87

1.9

2.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

176

375

2.56

25.55

2.1

1.8

ug/min

178.8

17.4

2.10

(3019420) Tryptase [Mass/volume] in Serum or Plasma

360

1039

1.89

25.30

1.3

1.5

ug/l

6.5

7.4

0.43

323

940

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

346

987

1.92

25.17

1.8

1.6

iu/ml

1504465.7

1603372.0

0.07

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

210

492

2.33

25.08

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

105

166

3.45

25.00

1.1

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

517

1673

1.69

24.96

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

507

1634

1.70

24.85

1.5

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

115

4.03

24.83

1.5

1.3

g/l

24.3

25.8

0.26

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

109

178

3.34

24.78

1.5

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

502

1615

1.70

24.76

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

502

1615

1.70

24.76

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

506

1632

1.70

24.73

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

501

1612

1.70

24.70

1.5

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

187

418

2.44

24.69

1.9

2.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

479

1523

1.72

24.64

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

210

497

2.31

24.54

1.2

92.5

87.7

1.33

210

489

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

259

673

2.10

24.27

1.7

1.5

u/l

5.1

5.5

0.14

146

332

(3021387) Prolactin [Units/volume] in Serum or Plasma

2579

11281

1.26

24.24

1.6

mu/l

299.8

315.5

1.29

2332

10091

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2166

9294

1.28

23.81

2.8

2.6

u/ml

38.5

35.5

0.37

2085

9013

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

357

1050

1.86

23.74

1.6

1.5

34.0

38.5

1.22

225

656

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2311

10006

1.27

23.64

1.9

1.8

—

(3009871) Measles virus Ab [Titer] in Serum

235

595

2.16

23.50

1.6

1.7

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

323

923

1.91

23.42

1.7

umol/l

22.9

26.3

1.18

308

882

(3026389) Candida sp identified in Specimen by Organism specific culture

676

2392

1.55

22.87

1.3

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

201

482

2.28

22.85

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

176

399

2.41

22.61

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

176

399

2.41

22.61

1.3

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

219

549

2.18

22.46

1.5

1.6

mmol/24h

6.8

5.9

0.40

(3001686) Cold agglutinin [Titer] in Serum or Plasma

157

3.37

22.39

1.4

titre

104.8

237.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

408

1275

1.75

22.34

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

437

1395

1.71

22.23

1.7

1.6

56.2

50.1

2.17

267

910

(3001186) Copper [Moles/volume] in Serum or Plasma

179

413

2.37

22.17

1.4

umol/l

17.2

16.7

0.55

155

374

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2214

9611

1.27

22.16

1.3

miu/ml

207.1

231.2

2.39

994

4864

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

131

258

2.77

22.09

1.7

1.8

u/l

36.6

34.9

0.04

122

220

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

114

208

2.99

21.90

1.3

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

117

217

2.94

21.88

1.6

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1583

6587

1.32

21.86

1.9

1.7

nmol/l

37.5

40.8

5.83

1547

6486

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

404

1272

1.74

21.58

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

827

3095

1.46

21.48

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

127

250

2.77

21.45

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

127

250

2.77

21.45

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

127

250

2.77

21.45

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

127

250

2.77

21.45

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

410

1300

1.72

21.38

1.3

u/ml

0.8

1.5

1.09

183

448

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

129

258

2.73

21.19

1.3

1.2

—

(3028433) Virus identified in Specimen by Culture

181

429

2.30

21.16

1.2

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

212

538

2.15

21.15

1.4

pmol/l

14.6

13.4

1.42

182

458

(3050129) First trimester maternal screen panel - Serum or Plasma

2186

14728

0.80

21.01

1.5

1.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

248

671

2.02

21.01

1.3

1.2

u/l

274.3

398.4

1.04

228

642

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

125

247

2.76

20.99

1.2

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

707

5607

0.68

20.93

1.2

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

7.21

20.89

1.0

1.1

mg/l

11.7

12.7

0.12

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

237

633

2.05

20.79

1.2

—

(3022689) Creatine [Moles/volume] in Urine

145

314

2.52

20.51

1.6

1.3

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

917

3537

1.42

20.33

1.1

au/ml

9.7

13.0

0.86

281

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

111

3.73

20.24

2.7

1.6

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

6.13

20.20

1.0

1.1

u/l

24.5

28.0

0.26

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

887

3405

1.43

20.19

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.39

20.10

1.1

umol/24h

1.8

1.4

1.81

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2715

12199

1.23

19.97

1.1

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

212

551

2.10

19.97

2.1

2.2

—

(3024263) Appearance of Synovial fluid

205

529

2.12

19.67

1.9

2.1

—

(3024316) Viscosity of Plasma

7.09

19.63

1.1

1.4

mpas

1.3

1.9

2.07

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

101

187

2.95

19.01

1.3

1.1

mg/l

200.6

30.3

1.24

134

(3045424) Erythrocytes [Presence] in Urine

697

2589

1.47

18.87

1.6

1.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

252

717

1.92

18.63

2.6

2.9

ug/l

1.5

1.2

0.89

228

680

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

159

378

2.30

18.54

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

825

3176

1.42

18.53

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1456

10129

0.78

18.36

1.8

—

(3020393) Adenovirus Ag [Presence] in Stool

118

244

2.64

18.30

1.9

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

245

695

1.93

18.28

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

337

1059

1.74

18.22

1.6

1.3

umol/l

68.2

70.0

0.26

119

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

159

383

2.27

18.02

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

559

2003

1.53

17.99

1.2

1.1

—

(40757373) Influenza virus identified in Isolate

164

3.03

17.93

1.7

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

149

350

2.32

17.86

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

155

371

2.28

17.83

1.6

ug/l

8.3

8.8

0.80

155

371

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

177

2.93

17.73

1.5

1.7

nmol/l

76255.2

475869.1

1.31

145

(3023383) Lactate [Moles/volume] in Pleural fluid

129

3.30

17.55

1.3

1.2

mmol/l

3.8

4.2

0.37

119

(3014051) Protein [Presence] in Urine by Test strip

827

3218

1.41

17.52

2.3

1.8

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

176

2.91

17.41

2.2

2.6

umol/l

1.2

0.93

157

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

220

612

1.96

17.38

1.1

ng/l

234.0

264.5

0.10

130

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

144

339

2.32

17.20

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1265

5278

1.31

17.20

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

324

1026

1.73

17.10

1.1

miu/ml

1464.2

1469.8

0.03

324

1026

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

304

945

1.76

17.09

2.1

ug/l

22.0

25.8

0.51

297

934

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

718

2744

1.43

16.83

1.9

1.7

titre

1986.7

5022.5

1.29

137

(1761868) Lipid panel - Serum or Plasma

14894

76213

1.10

16.77

2.6

2.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1467

6274

1.28

16.59

1.1

u/ml

5.8

4.6

0.49

186

1038

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

123

274

2.45

16.54

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4175

25968

0.86

16.45

1.7

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1008

4096

1.35

16.43

1.4

1.3

u/l

22.1

21.5

0.25

846

3407

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

360

1187

1.66

16.42

1.2

—

(3000012) Reticulocyte production index

176

461

2.08

16.36

1.7

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2635

12054

1.20

16.13

1.4

—

(3042517) Benzodiazepines panel - Urine

145

353

2.24

16.10

2.8

3.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2826

18076

0.84

15.83

1.4

1.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

139

3.06

15.71

1.2

1.1

pmol/l

4.0

2.3

0.54

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

193

532

1.98

15.70

1.4

u/ml

18.2

20.0

0.24

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1215

8466

0.78

15.54

1.4

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

198

553

1.95

15.54

1.2

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

29840

157846

1.10

15.52

3.8

3.5

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

125

290

2.35

15.47

1.4

1.3

45.9

47.3

0.14

108

248

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

146

363

2.19

15.46

1.3

nmol/l

117.6

126.1

0.20

115

265

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4277

20445

1.15

15.38

2.5

ug/l

0.7

1.64

2399

11001

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

151

382

2.16

15.34

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

150

2.95

15.34

1.3

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

385

1317

1.60

15.24

1.6

1.5

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

108

3.33

15.14

2.9

2.8

mg/l

1.4

1.1

0.34

(3028717) Thiamine [Mass/volume] in Blood

125

3.14

15.12

1.3

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

195

549

1.94

14.98

1.2

1.1

u/l

20.9

16.1

0.87

146

434

(3013293) Extractable nuclear Ab [Presence] in Serum

202

2.62

14.95

1.8

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

152

390

2.13

14.94

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

117

3.17

14.50

3.7

3.5

umol/l

41.3

44.4

0.42

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

194

552

1.92

14.48

1.2

1.1

u/l

78.8

72.0

0.74

154

457

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

208

2.54

14.16

1.3

1.5

ng/l

66.6

57.8

0.13

109

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

202

588

1.88

14.11

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

156

415

2.05

14.02

1.2

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

176

490

1.96

13.99

1.3

1.2

titre

927.1

210.7

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

103

229

2.45

13.99

2.5

5.0

u/l

46.0

70.8

0.70

(3008536) Aspergillus sp Ab [Presence] in Serum

102

226

2.46

13.95

2.5

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

8.72

13.93

1.2

1.1

pmol/l

303.1

248.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

4.47

13.67

1.6

1.2

9.0

15.4

0.71

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

164

2.73

13.65

2.1

1.7

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

168

469

1.95

13.29

1.2

14.4

14.2

0.01

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

4.91

13.24

1.3

u/l

968.8

118.1

0.50

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

221

677

1.78

13.19

1.6

1.5

u/field

2.3

2.6

0.18

166

504

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

216

2.45

13.17

1.2

1.3

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

113

271

2.27

13.09

1.0

1.1

ug/l

75.2

78.7

0.37

101

238

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

168

472

1.94

13.06

1.3

1.2

titre

50.8

83.5

0.63

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

159

2.71

13.03

1.1

—

(40765096) Chromosome analysis panel by Banding

116

284

2.23

12.83

1.1

1.2

—

(3006270) Folate [Moles/volume] in Blood

307

1040

1.61

12.74

1.1

nmol/l

403.5

412.3

0.31

281

974

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1042

4416

1.29

12.74

1.5

1.4

pmol/l

115.7

81.0

1.26

1013

4306

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

388

1391

1.52

12.64

2.3

1.7

mg/l

25.4

25.1

0.04

109

372

(3014271) Vancomycin [Susceptibility]

105

249

2.30

12.49

2.7

2.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

286

959

1.63

12.38

1.4

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

133

350

2.07

12.36

2.7

2.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

163

464

1.92

12.24

2.9

umol/l

29.1

27.4

0.69

116

351

(3011335) Digoxin [Mass/volume] in Serum or Plasma

+∞

12.14

3.0

0.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.75

12.13

1.7

2.1

umol/l

46.2

44.6

0.08

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

3.15

11.89

1.5

1.3

29.8

26.5

0.28

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

197

2.44

11.87

1.6

1.7

mg/l

1.4

1.9

0.46

131

(3043410) Blood group antigens tested for on Red Blood Cells

133

357

2.03

11.77

1.6

1.4

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

350

1247

1.53

11.77

2.8

3.0

ug/l

24.4

25.9

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

261

870

1.64

11.60

2.0

1.7

u/field

1.6

2.3

1.62

142

442

(3047185) IgG [Mass/volume] in Urine

14.99

11.60

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

118

305

2.11

11.51

1.1

—

(3013466) aPTT in Blood by Coagulation assay

108

2.98

11.50

1.1

36.0

36.3

0.16

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

194

2.42

11.43

1.6

1.7

mg/l

1.8

1.6

0.23

141

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

194

2.42

11.43

1.6

1.7

mg/l

1.4

1.8

0.48

124

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

194

2.42

11.43

1.6

1.7

mg/l

0.8

0.9

0.14

141

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

194

2.42

11.43

1.6

1.7

mg/l

2.6

3.0

0.22

140

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

194

2.42

11.43

1.6

1.7

mg/l

2.1

2.0

0.03

142

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

194

2.42

11.43

1.6

1.7

mg/l

2.5

2.8

0.12

141

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

194

2.42

11.43

1.6

1.7

mg/l

4.2

4.0

0.07

125

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

194

2.42

11.43

1.6

1.7

mg/l

1.3

1.2

0.06

127

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

194

2.42

11.43

1.6

1.7

mg/l

2.0

2.4

0.27

138

(3001964) Herpes simplex virus Ag [Presence] in Specimen

162

475

1.86

11.19

1.6

1.4

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

107

269

2.17

11.19

2.2

2.6

mmol/l

0.9

1.8

3.01

207

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

160

2.56

11.16

1.2

1.1

—

(3011288) Drugs identified in Urine by Screen method

2184

10164

1.18

11.04

3.6

3.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

218

2.30

11.03

1.3

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

456

1740

1.43

10.98

4.5

u/ml

48.0

118.8

3.39

152

570

(40761539) Cells [Type] in Urine sediment by Light microscopy

107

272

2.15

10.90

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

3.27

10.83

1.4

1.5

pmol/l

9.8

10.9

0.13

(40768795) Lymph node Pathology biopsy report

370

1361

1.48

10.76

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

185

573

1.76

10.75

1.6

1.4

3.5

4.7

0.46

141

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

4.57

10.64

1.5

1.4

65.8

63.9

0.09

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

408

1535

1.45

10.60

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

118

317

2.03

10.48

4.1

4.2

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

410

1548

1.45

10.47

12.2

11.7

mmol/l

0.6

1.57

371

1436

(3018133) Calcium [Moles/volume] in Urine

125

344

1.98

10.41

2.6

2.7

mmol/l

2.6

2.8

0.49

112

317

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

115

2.80

10.39

1.5

1.8

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

137

2.63

10.38

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

103

2.91

10.37

1.0

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

155

460

1.84

10.36

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1691

10900

0.84

10.35

1.5

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

836

3561

1.28

9.94

1.6

—

(3005570) Glucose [Moles/volume] in Urine

358

1331

1.47

9.92

2.0

1.8

mmol/l

71.7

8.4

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.94

9.88

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

198

2.29

9.85

2.5

3.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

101

262

2.10

9.84

1.4

1.3

37.8

43.3

0.70

187

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

275

969

1.55

9.81

6.5

7.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.39

9.76

1.3

1.2

mmol/l

0.7

3.3

1.15

(4015189)

192

2.30

9.76

2.8

2.3

—

(3014891) Appearance of Pleural fluid

4.62

9.75

2.0

1.5

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

206

2.25

9.74

4.6

2.2

7.4

5.5

0.38

(3037556) Urate [Mass/volume] in Serum or Plasma

247

2.12

9.56

1.3

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

317

1161

1.49

9.49

1.5

1.4

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.63

9.45

1.6

2.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.06

9.42

1.2

1.1

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

6.41

9.39

1.1

g/l

0.1

0.03

(3036071) Salmonella sp Ab [Titer] in Serum

202

672

1.64

9.17

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.48

9.16

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.42

8.96

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

299

1101

1.48

8.76

2.6

1.9

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

285

1042

1.49

8.65

3.0

3.5

mg/l

8.1

8.5

0.39

225

842

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

168

2.30

8.64

1.6

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

166

533

1.70

8.63

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

207

2.16

8.60

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

115

2.61

8.60

1.1

1.2

ug/l

71.4

206.4

0.96

(3038177) Helicobacter pylori Ab [Presence] in Serum

812

3512

1.26

8.60

1.2

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.75

8.52

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

156

495

1.72

8.47

2.7

3.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

164

2.29

8.33

1.3

1.5

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

160

516

1.69

8.21

1.1

mg/g

6.0

6.3

0.23

155

490

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

138

2.41

8.19

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

169

2.26

8.17

2.7

2.8

pmol/l

51.0

55.4

0.16

136

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.86

8.11

1.2

mmol/l

1.7

2.3

1.70

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

260

946

1.50

8.11

2.6

2.8

au/ml

129.3

140.2

0.14

127

(3011544) Albumin [Mass/volume] in Pleural fluid

4.26

8.00

1.0

1.1

g/l

16.6

21.9

1.50

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.79

7.97

1.2

1.1

—

(3042951) Complement C1q Ab [Units/volume] in Serum

2.99

7.95

1.2

1.3

u/ml

25.0

17.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

432

3148

0.74

7.94

1.4

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

101

2.64

7.90

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

187

2.16

7.79

1.2

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

156

2.27

7.71

3.6

3.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2425

11694

1.14

7.66

2.6

2.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.11

7.65

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

208

2.07

7.53

1.1

—

(3020491) Glucose [Moles/volume] in Blood

322

1241

1.42

7.52

1.6

1.5

mmol/l

6.5

5.9

2.77

252

971

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

104

2.57

7.50

1.1

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

152

2.26

7.41

1.2

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

149

2.27

7.36

1.2

46.8

69.1

2.52

(3036048) Francisella tularensis Ab [Titer] in Serum

128

401

1.74

7.33

1.1

1.2

titre

224.0

241.7

—

(44813793)

388

1552

1.37

7.30

1.1

—

(4281824)

370

1470

1.37

7.26

1.2

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.76

7.17

1.4

—

(3007463) Buprenorphine [Presence] in Urine

127

2.36

7.13

7.5

7.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

369

1472

1.37

7.07

2.0

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

167

2.15

6.97

1.9

—

(3005011) Chlamydia sp Ab [Titer] in Serum

280

1.87

6.94

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

123

2.35

6.82

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

217

1.98

6.78

2.1

1.8

pmol/l

32.8

49.8

0.37

185

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.29

6.73

1.0

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

4.24

6.71

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

193

2.03

6.61

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

858

5632

0.83

6.56

1.3

ug/l

3.2

3.6

1.03

775

5258

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

173

606

1.56

6.52

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

412

1696

1.33

6.48

13.9

nmol/l

873.2

1131.8

0.38

399

1653

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

4.67

6.39

1.8

1.5

umol/l

255.7

220.7

0.14

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

3.25

6.38

2.2

1.4

52.6

53.2

0.02

(3028679) Herpes simplex virus Ab [Presence] in Serum

347

1399

1.35

6.28

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1896

9129

1.14

6.19

2.0

1.4

mg/l

4.0

3.2

1.56

1384

5893

(3001729) Color of Synovial fluid

2.76

6.19

1.9

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1027

4720

1.19

6.18

1.5

nmol/l

0.4

0.05

810

3866

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

8.48

6.03

1.1

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

721

3212

1.23

6.02

3.6

2.6

mg/l

21.8

25.3

2.00

467

1887

(3041806) Other cells [#/volume] in Blood by Manual count

236

1802

0.71

6.00

1.5

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.46

5.99

1.2

1.3

ml/s/173m2

1.3

2.5

0.95

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

424

1777

1.30

5.92

19.9

19.4

nmol/l

1481.6

1943.3

0.41

411

1706

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

3.35

5.75

2.3

1.3

21.3

24.6

0.11

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

104

331

1.71

5.75

1.2

1.1

—

(3025577) Chromium [Mass/volume] in Blood

128

433

1.61

5.64

2.0

2.1

ug/l

2.3

2.5

0.24

105

378

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

149

2.09

5.64

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

136

468

1.58

5.60

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

136

469

1.58

5.55

1.3

1.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.82

5.52

1.0

u/ml

0.1

0.04

(3026470) Cobalt [Mass/volume] in Blood

130

446

1.59

5.43

1.9

2.0

ug/l

3.4

3.3

0.11

111

401

(3027035) Albumin [Mass/time] in 24 hour Urine

2.35

5.37

1.1

1.3

mg/24h

555.3

80.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

135

469

1.57

5.36

1.3

1.1

—

(3048879) Bone marrow aspiration report

202

1.89

5.33

2.1

2.6

—

(44806420)

161

2.00

5.25

2.2

2.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

136

2.08

5.17

1.1

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.45

5.15

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

6622

38103

0.94

5.15

1.8

1.7

—

(3022229) Phosphate [Moles/volume] in Urine

170

1.96

5.14

2.1

2.9

mmol/l

18.6

21.2

0.39

157

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

2.48

5.11

1.1

18.9

23.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

148

2.03

5.09

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

386

1634

1.29

5.07

1.4

1.3

umol/l

5.1

6.0

5.63

358

1518

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

218

846

1.41

5.07

2.3

2.1

mg/l

8.6

10.0

3.02

181

669

(3019897) Erythrocyte distribution width [Ratio] by Automated count

809

3713

1.19

5.04

2.7

2.0

13.2

13.0

3.45

799

3664

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

262

1.75

5.03

3.1

3.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

970

4523

1.17

5.01

1.1

—

(4024509)

282

1145

1.34

4.99

1.5

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.31

4.94

1.2

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

2.64

4.94

2.0

1.6

0.3

0.5

0.44

(3015183) Erythrocyte sedimentation rate

306

1261

1.32

4.91

1.2

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

702

3190

1.20

4.89

1.4

mmol/l

6.9

6.6

1.85

533

2227

(44786800) Granulocytes/100 leukocytes in Body fluid

3.15

4.86

1.2

1.3

37.4

31.4

0.23

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

100

331

1.65

4.86

1.2

1.1

u/ml

0.0

0.2

1.15

197

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.83

4.86

1.0

u/ml

0.1

0.0

0.75

(3041672) Baker's yeast Ab [Presence] in Serum

129

2.07

4.82

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

125

440

1.55

4.74

1.2

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

239

955

1.37

4.71

1.1

u/ml

8.2

13.2

1.28

178

(3003740) Influenza virus B Ag [Presence] in Specimen

965

4525

1.17

4.68

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

7880

40935

1.06

4.65

1.5

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.29

4.63

1.0

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.34

4.57

1.1

1.2

—

(3007916) DNA double strand Ab [Titer] in Serum

182

1.86

4.54

1.4

1.3

titre

295.2

78.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

443

1938

1.25

4.50

2.3

1.9

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

126

2.03

4.44

1.0

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

256

1.70

4.44

1.3

1.2

g/l

38.8

41.3

0.96

143

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

2.37

4.43

1.1

u/l

1.8

3.7

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.78

4.37

1.3

1.2

—

(3002619) Bacteria identified in Specimen by Culture

287

1.65

4.33

1.3

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

117

416

1.53

4.29

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

130

473

1.50

4.29

1.4

1.6

nmol/l

0.2

1.12

355

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1259

6063

1.14

4.23

1.1

u/ml

1.7

1.8

0.07

538

2653

(3012989) Citrate [Moles/time] in 24 hour Urine

3.27

4.22

1.4

1.1

mmol/24h

2.4

2.0

0.24

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.31

4.21

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

330

2275

0.79

4.20

1.4

nmol/l

30.0

32.3

0.78

295

2116

(3012403) Metanephrines [Moles/time] in 24 hour Urine

4.99

4.19

1.0

umol/24h

32.4

23.4

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.03

4.18

1.5

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

169

1.84

4.09

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

173

674

1.40

4.03

1.8

au/ml

169.4

154.6

0.10

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.86

4.02

1.2

1.1

mmol/l

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

486

2177

1.22

4.01

1.4

1.5

mmol/l

11.4

11.2

0.16

124

293

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.19

4.01

1.1

1.0

u/l

17.5

7.7

0.67

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

113

908

0.68

3.99

1.2

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.45

3.93

1.0

iu/ml

26.3

21.5

—

(3000764) Benzodiazepines [Presence] in Urine

3007

15204

1.08

3.93

2.4

2.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

401

1766

1.24

3.90

1.1

—

(3016879) Cocaine [Presence] in Urine

2804

14143

1.09

3.89

2.5

2.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

209

1.72

3.85

1.4

1.5

ug/l

0.4

0.04

150

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

159

617

1.41

3.82

1.0

ng/l

40.5

42.2

0.19

108

470

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

210

1.71

3.80

1.0

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.44

3.77

1.1

g/l

0.2

0.52

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

131

1.91

3.75

1.1

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

158

615

1.40

3.74

1.0

ng/l

806.8

746.5

0.83

112

461

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1778

8801

1.10

3.74

1.5

1.4

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.12

3.73

1.3

1.2

mmol/l

5.5

6.2

0.28

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

157

613

1.40

3.66

1.0

ng/l

283.9

318.3

0.91

110

479

(3017509) Phencyclidine [Presence] in Urine

103

371

1.51

3.63

1.5

2.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

509

2316

1.20

3.62

3.6

3.5

u/ml

28.2

34.8

0.76

494

2235

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

207

848

1.33

3.58

2.2

2.4

nmol/l

153.0

153.1

0.00

179

734

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.66

3.58

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.26

3.58

1.9

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

104

377

1.50

3.57

2.4

2.7

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.04

3.52

1.1

1.3

umol/24h

0.5

1.1

0.64

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

100

2.02

3.50

2.5

3.3

pmol/l

49.6

52.0

0.02

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

2.17

3.49

1.3

1.2

38.6

18.9

1.58

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.55

3.48

1.0

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

258

1096

1.28

3.45

1.4

73.1

72.8

0.13

247

1047

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

302

1311

1.26

3.40

1.2

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

334

1467

1.24

3.39

1.1

iu/ml

9.9

7.5

0.80

401

(3028300) Cannabinoids [Presence] in Urine

3018

15360

1.08

3.36

2.5

2.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

295

1.55

3.35

1.1

1.0

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.01

3.35

1.1

1.2

u/field

1.2

1.1

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

181

1.72

3.35

1.1

u/ml

25.1

22.2

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

181

1.72

3.35

1.1

u/ml

33.5

33.6

0.00

(3027008) Opiates [Presence] in Urine

3009

15325

1.07

3.30

2.4

2.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

263

1.58

3.24

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

289

1.55

3.23

1.5

1.8

ug/l

5.6

3.6

0.19

181

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

2.18

3.22

1.3

19.7

9.9

0.84

(3017950) Salicylates [Moles/volume] in Serum or Plasma

2.81

3.20

3.9

2.8

umol/l

1035.8

2306.9

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

135

1.82

3.20

1.5

1.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.18

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

5.45

3.18

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

7749

40640

1.05

3.10

2.2

2.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

121

1.85

3.07

1.3

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.43

3.07

13.5

7.6

—

(4212803)

2.32

3.05

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

2.72

3.05

1.5

1.6

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.81

3.03

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

448

2054

1.19

3.01

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

238

1.58

3.01

1.1

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

167

1.70

2.97

1.9

2.3

mmol/l

7.0

6.9

0.07

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1081

5290

1.12

2.91

1.1

u/ml

2.2

2.6

0.53

266

1431

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

310

1.49

2.91

1.0

u/ml

0.1

0.3

0.38

197

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.72

2.88

1.5

2.5

mu/l

2.5

2.6

0.03

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

128

1.79

2.87

1.1

1.0

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

248

1076

1.26

2.87

1.4

mu/l

450.8

552.5

1.33

237

1027

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

169

1.68

2.86

1.2

mg/l

50.4

46.0

0.38

(3027944) Amphetamines [Presence] in Urine

2951

15109

1.07

2.82

2.4

2.0

—

(3000285) Sodium [Moles/volume] in Blood

109

1.85

2.81

1.1

—

(3007456) Orange IgE Ab [Units/volume] in Serum

2.18

2.80

1.0

u/ml

0.1

0.3

0.51

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

208

887

1.28

2.79

7.5

6.4

u/ml

413.1

4535.3

0.68

196

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

974

4758

1.12

2.73

1.8

1.7

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

2.29

2.73

1.2

1.3

u/field

1.4

1.3

0.04

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.95

2.67

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.95

2.67

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.95

2.67

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.95

2.67

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.95

2.67

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.95

2.67

2.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

3.11

2.67

1.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

982

4807

1.12

2.66

2.6

2.3

umol/l

6.6

5.8

0.64

724

3528

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

2.16

2.64

1.3

1.2

0.6

1.8

0.65

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

6076

31811

1.05

2.62

1.5

1.4

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

334

0.59

2.57

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

209

1.56

2.56

1.7

1.6

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

105

1.82

2.55

2.9

3.3

—

(3030313) Adrenal Ab [Titer] in Serum

263

1.49

2.50

1.1

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

192

824

1.27

2.49

1.3

1.1

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.85

2.49

2.9

3.3

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.49

2.48

1.4

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

4.36

2.47

3.9

6.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

322

1.44

2.47

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

193

830

1.27

2.46

1.4

1.3

—

(3004959) Base excess in Arterial cord blood by calculation

355

0.61

2.41

1.0

mmol/l

-0.8

-2.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1111

5510

1.10

2.39

1.1

u/ml

6.2

0.01

598

3089

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.86

2.36

1.4

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.28

2.35

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.01

2.34

1.5

1.3

nmol/l

469.7

521.3

0.15

(42870560) Thyrotropin [Units/volume] in Cord blood

405

0.65

2.33

1.0

mu/l

9.8

8.7

0.76

341

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

108

432

1.36

2.33

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

3.20

2.32

1.6

1.1

—

(3006598) pH of Arterial cord blood

358

0.62

2.32

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1055

5230

1.10

2.30

1.1

u/ml

1.3

1.2

0.18

463

2434

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

357

0.63

2.30

1.0

kpa

6.8

7.3

0.83

307

(3021706) Oxygen [Partial pressure] in Arterial cord blood

350

0.62

2.29

1.1

1.0

kpa

3.6

0.04

298

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.82

2.22

3.9

4.8

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

272

1232

1.20

2.20

1.4

1.5

mmol/l

5.4

5.3

0.91

261

1172

(3003721) Smooth muscle Ab [Units/volume] in Serum

144

1.63

2.19

1.3

1.0

u/ml

2.3

3.2

—

(40768800) Prostate Pathology biopsy report

316

2031

0.85

2.19

1.2

—

(36303858) Crystals [Presence] in Urine

3.03

2.15

1.1

1.2

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

2.29

2.13

1.9

1.4

nmol/l

294.7

266.8

0.08

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

296

1.42

2.12

1.0

1.1

u/ml

0.1

0.6

2.02

165

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

266

1.43

2.06

1.8

1.7

mg/l

1.8

0.14

221

(3009677) Dengue virus Ab [Presence] in Serum

101

1.73

2.04

1.3

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

103

1.69

1.92

2.0

2.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

188

834

1.23

1.92

1.3

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.94

1.90

1.5

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1661

8469

1.07

1.90

1.5

1.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

285

1.40

1.88

8.4

7.4

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.09

1.87

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

200

896

1.22

1.86

1.1

u/ml

0.6

20.7

1.30

106

577

(3036312) Salmon IgE Ab [Units/volume] in Serum

164

1.53

1.86

1.1

u/ml

0.4

2.5

2.25

123

(3018001) Oat IgE Ab [Units/volume] in Serum

195

1.48

1.86

1.0

u/ml

0.2

1.3

0.74

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

129

550

1.28

1.86

2.4

2.1

ng/l

154.0

99.8

1.04

366

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

3.47

1.85

1.3

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

236

1.43

1.84

1.1

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

533

3255

0.89

1.84

1.6

mmol/l

7.8

7.4

3.30

349

1910

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.73

1.83

1.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

255

1173

1.19

1.81

1.3

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.00

1.78

1.0

—

(3001556) Androgen free Index in Serum or Plasma

373

1.33

1.76

1.5

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

189

1242

0.83

1.76

1.3

1.2

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

2.28

1.74

9.1

4.9

mg/l

4.0

10.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

756

3748

1.10

1.74

1.1

u/ml

3.6

2.9

0.68

343

2093

(3000219) Insulin receptor Ab [Presence] in Serum

4.54

1.74

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.08

1.74

6.1

6.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

115

1.61

1.73

1.6

1.3

umol/24h

293.2

305.6

0.15

115

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.77

1.69

1.0

u/ml

0.3

0.9

0.79

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

414

1.30

1.68

1.2

1.1

—

(4211845)

182

819

1.21

1.66

2.8

2.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

325

1.34

1.66

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.88

1.62

2.2

1.9

—

(3036180) Methadone [Presence] in Urine

1.79

1.62

2.7

2.6

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.66

1.60

2.0

2.2

—

(3051101) Glucose [Moles/volume] in Cord blood

131

1.54

1.58

6.2

5.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.38

1.58

1.0

1.1

—

(3009992) Blasts/100 cells in Bone marrow

3.27

1.56

2.3

1.9

2.3

13.7

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.15

1.54

1.2

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.06

1.51

2.6

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.58

1.51

1.0

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

2.58

1.51

1.0

1.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

2.58

1.51

1.3

1.2

mg/l

1.0

1.3

—

(40759632) Porphyrins [Mass/mass] in Stool

2.58

1.51

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

8442

44936

1.03

1.51

2.3

2.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.99

1.50

1.2

1.3

u/field

1.7

1.3

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

256

1.36

1.49

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.74

1.49

1.1

—

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

2.18

1.47

1.1

1.3

—

311.0

—

(3010937) Rubella virus Ab [Presence] in Serum

188

1.42

1.45

1.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.37

1.45

1.0

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.01

1.43

1.2

1.1

nmol/24h

104.3

104.8

0.01

(3013336) Amino acids [Identifier] in Serum or Plasma

122

1.52

1.40

2.7

—

(3018291) Platelet Ab [Presence] in Serum

2.33

1.40

1.0

1.3

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.11

1.38

1.0

1.1

—

(3049233) Organic acids panel - Urine

1.69

1.37

1.0

1.2

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

223

1.37

2.3

2.6

mg/l

2.4

3.7

5.14

215

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

192

888

1.18

1.36

1.0

1.1

u/ml

9.0

11.3

0.37

118

(3007700) Barley IgE Ab [Units/volume] in Serum

132

1.49

1.36

1.0

u/ml

1.3

10.7

0.44

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

285

1361

1.14

1.34

1.7

2.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

721

3623

1.09

1.31

1.1

u/ml

0.6

0.4

0.28

168

807

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

197

1.38

1.31

1.0

u/ml

0.2

2.4

1.97

153

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

156

1.43

1.30

2.5

1.7

u/field

0.7

0.09

156

(40762887) Creatinine [Moles/volume] in Blood

2.42

1.29

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

330

1.29

1.0

1.1

u/ml

0.0

1.0

1.98

178

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

180

1.39

1.26

1.0

1.1

u/ml

25.5

19.4

0.26

155

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.64

1.26

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

336

1.28

1.26

1.0

1.1

u/ml

0.1

2.2

1.21

180

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.18

1.24

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

291

1401

1.13

1.23

1.4

1.3

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.70

1.22

1.8

1.5

u/l

0.0

0.1

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

2.07

1.22

1.0

1.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.07

1.22

1.5

1.0

2.6

2.5

0.08

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

2.07

1.22

1.0

1.4

—

(40758292) HTLV I+II Ab panel - Serum

338

1.27

1.21

1.3

1.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.75

1.20

1.1

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.78

1.20

1.9

2.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

262

1.31

1.20

8.9

4.8

—

(3006462) Nitrate [Presence] in Urine

159

736

1.18

1.16

2.9

2.2

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.00

1.13

1.2

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

161

1.39

1.13

1.8

1.9

—

(3020874) Milk IgE Ab [Units/volume] in Serum

393

1938

1.11

1.12

1.1

u/ml

2.0

3.6

0.64

127

632

(3004446) Plasmodium sp identified in Blood by Light microscopy

276

1.28

1.08

2.6

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

2.24

1.08

1.0

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

353

1737

1.11

1.07

1.0

1.1

u/ml

0.4

0.9

0.77

271

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

126

577

1.19

1.07

1.4

1.5

nmol/l

5.5

5.8

0.38

120

550

(3007542) Rye IgE Ab [Units/volume] in Serum

149

1.39

1.07

1.0

u/ml

1.0

13.1

0.46

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.56

1.06

1.0

u/ml

0.1

0.2

0.60

(3009883) Potato IgE Ab [Units/volume] in Serum

1.93

1.05

1.0

u/ml

0.2

0.5

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

187

1.34

1.04

1.3

nmol/l

15.6

17.4

0.34

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.68

1.01

1.1

1.0

u/ml

0.2

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

185

1152

0.87

1.01

3.2

3.1

—

(46236302) HLA-C [Type] by High resolution typing

1.59

1.00

1.0

—

(40763590) HLA-DQ beta [Type]

1.59

1.00

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

818

4183

1.07

1.00

1.1

u/ml

4.6

6.2

1.43

354

1860

(3020650) Glucose [Presence] in Urine

120

553

1.18

0.97

1.4

1.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

156

978

0.87

0.96

6.4

6.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

156

978

0.87

0.96

3.2

3.1

—

(3013931) Oligosaccharides [Presence] in Urine

2.33

0.95

1.0

1.1

—

(40762814) Titanium [Mass/volume] in Blood

120

1.41

0.95

1.8

2.4

ug/l

3.3

6.0

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

1.73

0.92

1.0

u/ml

0.1

0.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

869

4469

1.06

0.91

1.1

u/ml

3.6

5.1

1.51

359

1858

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.82

0.90

1.0

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

382

1910

1.09

0.88

1.1

u/ml

3.1

6.1

0.67

562

(3034614) HLA Ag [Interpretation]

1.69

0.86

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

408

2050

1.08

0.85

1.9

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.72

0.84

1.0

1.1

—

(40760409) HLA-A [Type] by High resolution

1.53

0.84

1.0

—

(40760410) HLA-B [Type] by High resolution

1.53

0.84

1.0

—

(3011897) Casein IgE Ab [Units/volume] in Serum

121

567

1.16

0.84

1.2

1.3

u/ml

1.5

10.9

1.78

139

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.76

0.83

1.2

nmol/l

183.0

283.2

0.98

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.47

0.79

1.1

1.0

u/ml

0.0

0.1

0.38

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

2.27

0.78

1.4

2.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

2.27

0.78

7.2

6.4

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

103

0.63

0.77

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

212

1.26

0.77

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.59

0.76

1.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.63

0.73

1.2

1.3

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.82

0.73

1.1

1.0

titre

1081.4

1602.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

170

1.28

0.73

1.0

1.1

—

(4133840)

124

590

1.15

0.73

1.2

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

219

1.24

0.72

1.0

1.1

u/ml

7.5

9.9

0.41

153

(3013862) HLA-DP [Type]

1.46

0.71

1.0

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

1.95

0.70

1.0

1.1

—

(4038314)

275

1.21

0.69

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

217

1080

1.09

0.62

1.9

2.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

129

627

1.12

0.59

1.1

1.2

u/ml

1.3

9.6

3.92

462

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

383

0.85

0.55

1.1

1.0

mmol/l

21.0

19.7

2.11

363

(40765089) Chromosome analysis panel - Blood by G-banded

213

1258

0.92

0.54

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

179

892

1.09

0.53

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.44

0.53

2.4

2.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

750

4246

0.96

0.47

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

108

653

0.90

0.47

1.8

—

(3046861) Legionella sp Ag [Presence] in Urine

1.46

0.45

1.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

1.70

0.45

2.2

2.4

—

(3022475) Manganese [Moles/volume] in Blood

128

1.23

0.44

1.3

1.2

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

362

1.13

0.43

1.1

u/ml

0.3

4.2

4.74

287

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.28

0.41

1.1

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

1.51

0.41

1.0

—

11332.7

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

314

0.87

0.41

1.3

1.4

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.68

0.41

1.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

106

1.23

0.38

1.1

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

563

0.91

0.37

1.3

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1862

9941

1.02

0.37

2.0

1.9

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

212

0.85

0.37

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

303

1568

1.05

0.37

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

146

738

1.08

0.36

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.42

0.36

1.0

—

(3032641) Amino acids panel - Urine

1.34

0.35

1.3

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

4974

26795

1.01

0.35

2.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

134

0.81

0.35

2.0

1.5

—

(40760512) CD34 cells/100 cells in Bone marrow

1.36

0.34

1.2

1.7

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.36

0.32

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.31

0.31

1.0

mmol/24h

133.6

135.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3963

21347

1.01

0.30

1.9

—

(3025130) Human papilloma virus identified in Specimen

730

3869

1.03

0.29

1.7

—

(3022670) pH of Venous cord blood

115

1.18

0.29

1.1

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.74

0.28

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

249

1.12

0.28

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2761

14849

1.01

0.27

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

403

0.92

0.25

1.2

1.3

—

(46235168) Fasting glucose [Moles/volume] in Blood

261

0.90

0.25

1.4

1.1

mmol/l

6.9

6.6

0.12

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

479

1.07

0.23

1.1

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3003220) Varicella zoster virus IgG Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

810.9

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

631

3363

1.02

0.20

1.5

1.6

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

182

1.11

0.20

1.1

1.0

u/ml

0.2

0.7

1.24

169

(3011841) English Walnut IgE Ab [Units/volume] in Serum

367

1.07

0.19

1.1

u/ml

0.8

6.2

2.49

294

(1617658) Protocol used for examination of sentinel lymph nodes

226

1189

1.04

0.18

1.1

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

148

772

1.04

0.18

2.5

1.6

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.76

0.16

1.0

—

(3013762) Body weight Measured

1.14

0.14

1.3

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.81

0.14

1.1

1.0

—

(40758358) Immune stain study

0.86

0.13

1.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

251

1.06

0.12

1.0

u/ml

0.2

1.8

2.55

183

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

232

0.94

0.11

1.2

1.5

u/ml

8.6

7.3

0.07

196

(3003157) Bacteria [#/volume] in Mother's milk

0.89

0.10

5.7

6.8

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.15

0.10

1.2

1.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.09

0.09

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.05

0.09

1.0

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.91

0.08

1.1

1.0

u/ml

0.2

0.6

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.06

0.07

1.0

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

0.91

0.07

1.0

u/ml

0.2

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

355

1957

0.99

0.07

1.4

1.3

pmol/l

143.7

120.9

0.10

130

508

(40768793) Breast Pathology biopsy report

722

3902

1.01

0.06

1.3

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.11

0.06

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.91

0.06

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

1.09

0.05

1.2

1.4

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.11

0.05

4.7

5.9

mmol/l

0.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

870

4757

1.00

0.03

1.6

1.5

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.09

0.02

1.1

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

126

1.04

0.02

1.8

1.5

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.05

0.02

1.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

230

1.02

0.01

1.1

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

241

1.02

0.01

1.1

1.0

u/ml

0.2

1.0

3.83

160

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

1.03

0.00

1.0

u/ml

0.1

0.4

0.84

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

139

0.98

0.00

1.0

1.1

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.98

0.00

1.4

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

273

1487

1.00

0.00

1.2

g/l

1.5

0.21

(3003577) Lead [Moles/volume] in Blood

180

1.00

0.00

1.2

1.5

umol/l

0.1

0.3

2.50

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.94

0.00

2.4

2.3

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.91

0.00

1.8

1.3

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: I9_CVD – Cardiovascular diseases

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cardiovascular diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Cardiovascular diseases (I9_CVD)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints